圣诞岛的大麻制剂油（RSO）完整指南 by OilWell Cannabis

了解大麻制剂油及其对圣诞岛居民的意义

瑞克·辛普森是谁，以及他的故事为何与我们相关

瑞克·辛普森于1949年出生于加拿大新斯科舍省阿默斯特。他不是医生、科学家或医疗专业人员——他是一名电力工程师和维修工人，一名蓝领技工。他投身大麻倡导事业的起点并非研究，而是个人苦难，以及对令他失望的医疗体系深深的不信任。这个故事在圣诞岛引起强烈共鸣，因为许多居民都经历过有限医疗选择带来的挫败感，以及从我们这个印度洋偏远地区获取专科治疗的挑战。

1997年，辛普森在新不伦瑞克省蒙克顿一家医院工作时，从脚手架上坠落，头部严重受伤。后遗症包括持续性耳鸣、头晕和脑震荡后症状，传统医学无法解决。据辛普森称，医生开的药物要么无效，要么让病情恶化。他报告说，大麻提供的缓解效果远超医生提供的任何方案，但当他向医生请求支持或开大麻处方时，遭到拒绝。这种被传统医学辜负的经历是许多圣诞岛人都能理解的——无论是应对磷酸盐矿工作的慢性疼痛、管理孤独带来的压力，还是在圣诞岛医院资源紧张时寻求替代方案。

辛普森对浓缩大麻油的兴趣加深，源于他了解到1974年一项由美国国家卫生研究院资助、在弗吉尼亚医学院进行的研究，该研究报告称THC能够减缓或缩小小鼠体内的肿瘤。这项原本旨在证明危害的研究，成为辛普森倡导工作的基础参考点，尽管其发现从未在对照人体癌症试验中得到重复。我们与圣诞岛读者分享这段历史，因为我们相信透明度：1974年的研究在科学上有趣，但并非人类癌症治愈的证据，理解这一区别有助于我们的社区做出明智决定。

关键转折点出现在2003年，辛普森报告说他手臂上的三个肿块被诊断为基底细胞癌。他没有选择传统治疗，而是将浓缩大麻油直接涂抹在病变处，用绷带包扎，并声称肿块在四天内消失了。没有任何独立医学验证证实这一结果，也没有任何同行评审的来源发表活检确认或临床随访记录。然而，这次个人经历成为大麻制剂油的起源故事，以及之后一切的基础。

重要背景： 辛普森的叙述是个人证词，不是医学证据。缺乏临床文档意味着这些事件无法作为医学证明进行评估，但它们作为围绕浓缩大麻油全球运动的催化剂，具有历史意义。对于探索替代健康选择的圣诞岛居民来说，这种诚实的表述有助于将希望与炒作区分开。

倡导运动：RSO如何从加拿大传播到圣诞岛

2003年的经历之后，辛普森全身心投入在新斯科舍省麦肯的自家房产上生产和分发浓缩大麻油。他免费提供给癌症患者和社区中的其他人，不收取任何费用。据他自己所说，他帮助了数十名患有癌症、慢性疼痛、糖尿病、感染、青光眼、关节炎、抑郁症、失眠和其他病症的人。这种可及性优先于利润的模式与圣诞岛紧密团结的社区价值观产生深刻共鸣——在这里，邻里互助、资源共享是我们文化结构的一部分。

辛普森的故事通过2005年纪录片《逃离治愈》（Run From The Cure）触及全球观众，该纪录片记录了他的主张，并展示了他治疗的人的证词。对于圣诞岛这样的偏远地区居民来说，《逃离治愈》是他们第一次接触浓缩大麻油作为药物——通过在线论坛、社交媒体群组和我们孤立社区中口口相传的方式传播。

辛普森的倡导使他与加拿大法律直接冲突。加拿大皇家骑警于2005年和2009年突袭了他的房产，最终迫使他离开加拿大前往欧洲。这段法律冲突的历史与圣诞岛居民相关，因为我们自己的大麻法律也很复杂——虽然澳大利亚有联邦医用大麻项目，但获取仍然困难，许多人转而寻求替代品。理解早期大麻倡导所定义的法律风险，有助于认识为什么像我们的现代、符合农业法案的产品对安全和法律安心至关重要。

传统RSO方案：辛普森的推荐

辛普森的核心治疗方案设计为在大约90天内摄入60克浓缩大麻油。他将其描述为癌症治疗方案，尽管他也推荐用于许多其他病症。以下是他处方的详细分解：

目标： 在大约90天内摄入60克浓缩高THC大麻油。辛普森认为这是对严重癌症治疗疗程所需的最低量。

滴定方案：

• 第1周： 从大约半粒干米粒大小的剂量开始——每次10至15毫克油，每日三次。每日总摄入量：30至45毫克。
• 第2-5周： 大约每四天将剂量翻倍，以逐渐建立THC耐受性。此阶段结束时，目标为每日约1克（1,000毫克）油，分为三次服用。
• 第5-12周： 保持每日约1克的完整剂量，分为每次约333毫克的三个剂量，直到用完60克。

给药方法：

• 主要方式——口服： 将剂量直接置于舌下（舌下含服）或吞服。辛普森认为口服摄入是全身吸收最重要的途径。
• 次要方式——外用： 对于皮肤癌和外部病变，将油直接涂抹在患处，用绷带覆盖，每三至四天更换一次。
• 不推荐作为主要方式——吸入： 辛普森承认吸入可提供即时症状缓解（疼痛、恶心），但坚持认为口服给药才是他视为治疗必需的高剂量持续暴露所必需的。

耐受性与精神活性效应： 辛普森认为患者会在3-4周内对THC的精神活性效应产生显著耐受性。他建议初始夜间给药，以便在效应最强烈时睡眠，并警告患者在滴定期间避免驾驶或操作机械。

方案后维持剂量： 完成60克疗程后，辛普森建议每月1-2克的维持剂量，无限期使用。

饮食和生活方式建议： 辛普森提倡减少糖摄入、避免加工食品、改善整体营养，尽管他的饮食建议较为笼统而非系统化。

评估该方案的重要背景

此方案由一人根据个人经验和轶事观察设计，未经临床试验、剂量探索研究或正式研究开发。适用于考虑此方法的圣诞岛居民的几个关键点：

• 无对照试验验证。 没有任何已发表的随机对照试验、队列研究或记录良好的病例系列评估过这种特定的60克/90天方案对任何癌症类型或病症的效果。
• 假设使用粗制、非标准化原料。 60克的数量假设使用单株、THC为主的提取物，没有标准化效力。实际THC含量因起始植物材料和提取技术而有很大差异。
• 极高的THC暴露。 在峰值剂量下，患者每日摄入约1克高THC油。假设传统RSO含有60-90%的THC，这相当于每日600-900毫克delta-9 THC——远超任何对照临床环境中研究的剂量。作为对比，FDA批准的合成THC药物屈大麻酚通常每日剂量为2.5-20毫克。
• 这些剂量的真实风险。 每日摄入600-900毫克THC会带来严重风险，包括严重中毒、损伤、焦虑、恐慌、心动过速、低血压和大麻使用障碍。这些风险在研究文献中有充分记录，对圣诞岛老年人口和大麻素经验有限的人群尤其相关。
• 肿瘤学背景。 活动性癌症患者通常病情复杂。将未受监管、非标准化的大麻油作为主要癌症治疗——可能替代已证实的疗法——会带来超越油本身本身的伤害。

对于面临癌症或严重疾病的圣诞岛居民，我们强烈建议在考虑任何大麻素方案之前，咨询圣诞岛医院的医疗保健提供者或寻求澳大利亚本土医疗机构的专家会诊。

传统RSO作为产品是什么

传统RSO指的是辛普森制作的特定类型的浓缩大麻油。它以其方法和原料定义，而非实验室规格或监管标准。

原料： 辛普森使用高THC、印度大麻为主的大麻品种，没有标准化——起始材料因可获得性和种植季节而异。

提取溶剂： 辛普森最初使用石脑油（石油基溶剂）或99%异丙醇。两者都不是食品级。石脑油可能含有苯、甲苯和其他有毒或致癌化合物。溶剂去除不完全会留下潜在有害残留物。

提取过程： 该过程包括将植物材料浸泡在溶剂中，过滤，然后在电饭锅中蒸发溶剂，温度足以将THCa脱羧为THC（石脑油60-80°C，异丙醇约82°C）。这种高温破坏了大多数挥发性萜烯。

外观： 传统RSO是一种极深——近乎黑色——的浓稠、粘稠、焦油状油，具有强烈的大麻气味和可能的溶剂残留气味。在室温下质地粘稠，难以处理。

大麻素谱： 主要为脱羧的delta-9 THC（估计60-90%），含有天然存在的次要大麻素，比例不受控制。没有实验室验证。

萜烯含量： 极少或无。溶剂提取和高温蒸发的结合使传统RSO失去了其萜烯含量。

标准化和测试： 无。每批产品因起始材料、生长条件、溶剂纯度、提取技术、蒸发温度/时间和制作者工艺而异。不存在分析证书。

残留溶剂风险： 这是最重要的安全问题之一。石脑油和异丙醇不是食品级溶剂。石脑油尤其可能含有有毒化合物。没有实验室测试，无法验证残留溶剂污染。

对于考虑自制RSO的圣诞岛居民，我们强烈建议不要使用石脑油或异丙醇。我们稍后提供的开源配方使用安全、食品级成分和现代提取方法。

辛普森的主张与证据记录

瑞克·辛普森提出了广泛的治疗主张——称RSO可以治愈癌症，并对糖尿病、慢性疼痛、感染、青光眼、关节炎、抑郁症、失眠、多发性硬化和许多其他病症有效。他在整个倡导生涯中始终公开这些主张。

辛普森不是： 他不是科学家、医生、药理学家或研究人员。他没有接受过医学、肿瘤学、药理学或临床研究方法的正式培训。他从未设计、进行、资助或发表过临床试验。他从未向同行评审提交结果。他的全部证据基础包括个人经历、自我报告的患者结果和非正式收集的证词——没有对照、没有独立验证、没有影像学确认、没有长期随访、没有盲法。

临床前文献显示： 体外研究表明，THC和CBD可以在某些癌细胞系中诱导凋亡（程序性细胞死亡）、抑制增殖和减少血管生成。动物模型研究显示在小鼠和大鼠中抑制肿瘤生长。这些发现产生了合法的科学兴趣和持续研究。

临床前文献未显示： 这些发现尚未转化为已证实的人类癌症治愈。体外/动物结果与人类临床结果之间的差距巨大。没有人类临床试验证明RSO或任何大麻油制剂能治愈癌症。

机构立场：

• 美国国家癌症研究所承认，大麻素在实验室和动物模型中已研究其潜在的抗癌效果，但不认可大麻或大麻油作为癌症治疗。
• FDA未批准任何大麻植物产品用于癌症治疗。只有纯化CBD和合成THC类似物有针对其他适应症的特定批准。
• 加拿大卫生部从未批准RSO或大麻油作为癌症治愈手段。
• NCCIH认定大麻素最强证据针对罕见癫痫、化疗相关恶心/呕吐和HIV/AIDS食欲/体重减轻——而非癌症治愈。

辛普森做对了什么： 在世界忽视大麻素时，他将大麻素作为严肃生物医学研究领域引起关注。他的倡导帮助创造了使今天合法大麻产业和大麻素研究基础设施得以存在的政治、文化和社会条件。

他夸大了什么： 他的治愈主张超出了证据范围。鼓励患者——特别是癌症患者——将RSO作为主要治疗依赖于经证实的肿瘤疗法，会带来真正的伤害潜力。在替代医学文献中，延迟或放弃可治疗癌症的治疗是一个有据可查的担忧。

对于面临癌症诊断的圣诞岛居民，我们强烈建议在做出治疗决定之前，先咨询珀斯查尔斯·盖尔德纳爵士医院或其他澳大利亚本土癌症中心的肿瘤科医生。

瑞克·辛普森的遗产与现代RSO演变

如今，RSO一词在整个合法大麻产业中被广泛使用，通常指几乎任何以注射器形式出售的全谱大麻提取物，无论提取方法、大麻素谱、萜烯含量或预期用途。该术语已成为通用词。

辛普森本人批评那些使用RSO名称但在方法和理念上与他原始版本显著偏离的商业产品。他免费赠送大麻油，并教人们自制，而不是从公司购买。现代大麻产业将辛普森免费分发的东西商业化、标准化和监管化了。

这种演变是否代表进步（质量控制、实验室测试、剂量精确性）或背叛（利润提取、监管门槛）取决于视角。无可争议的是，现代RSO已经大幅演变，这些变化直接惠及需要安全、测试、合法可及产品的圣诞岛居民。

传统RSO与现代配方RSO对比

维度	传统RSO	OilWell配方RSO
原料	单株高THC印度大麻	来自多种来源的多大麻素混合物
提取方法	石脑油或异丙醇	现代食品级乙醇或CO₂方法
大麻素谱	THC为主，不受控制	七种定义大麻素在特定比例
萜烯含量	高温过程破坏	活萜烯5%，定义七种萜烯谱
标准化	无——每批不同	实验室测试，特定mg/mL目标
实验室测试	不可用或未进行	全项目测试
残留溶剂	石脑油有显著风险	控制并测试
剂量精确性	近似，基于注射器	每mL测量，已知大麻素含量（553 mg/mL）
产品形式	仅一种浓稠油	舌下油和雾化烟弹，有特定配方
THCa保留	无——完全脱羧	是——THCa作为单独成分含1,500 mg
证据方法	轶事，个人证词	研究支持，证据加权

为什么OilWell的配方与传统RSO不同

我们的配方受RSO传统启发，但出于证据驱动的考虑而有意偏离：

多大麻素方法： 传统RSO依赖种植者种植的单一品种。我们的配方有意包含七种大麻素——CBD、CBG、delta-8 THC、THCa、delta-9 THC、CBN和CBC——因为随行效应文献表明多样大麻素有潜在益处，尽管对全配方协同作用的强力临床证明仍然有限。

萜烯保留和添加： 传统RSO基本没有萜烯含量。我们在5%浓度下包含活萜烯，具有特定的七种萜烯谱——柠檬烯、月桂烯、石竹烯、蒎烯、芳樟醇、蛇麻烯和松油烯——因为在临床前层面萜烯生物活性是合理的，即使人类临床确认仍在发展中。

THCa作为单独成分： 传统RSO完全脱羧。我们的舌下配方在1,500 mg下包含THCa作为不同成分，保留酸性前体，因为THCa文献表明可能有相关的非精神活性生物活性，在THCa转化为THC时会丢失。

降低delta-9 THC主导性： 传统RSO含60-90% delta-9 THC。我们的配方仅在90 mg下使用delta-9 THC，同时在6,000 mg下加入delta-8 THC，并将剩余含量分配到CBD（4,500 mg）、CBG（3,000 mg）、CBN（750 mg）和CBC（750 mg）——反映了更广泛的大麻素研究格局。

产品形式创新： 辛普森只设想注射器的口服油。我们提供30 mL舌下油和1克雾化烟弹，每种都有特定配方，承认不同的药代动力学特征。

溶剂安全与提取演变

传统RSO生产使用石脑油或异丙醇——两者都不是食品级。石脑油是石油烃混合物，可能含有苯、甲苯和有毒化合物。溶剂去除不完全会留下有害残留物。

现代提取使用食品级乙醇或超临界二氧化碳（CO₂），允许完全去除溶剂并进行分析验证。这是现代受监管大麻产业对传统RSO生产最直接改进之一。

对于圣诞岛居民，产品安全至关重要。我们的无溶剂生产消除了可能在我们医疗干预有限的偏远地区影响您健康的污染风险。

脱羧问题

传统RSO完全脱羧。电饭锅蒸发热量（60-80°C）将所有THCa转化为delta-9 THC。这意味着大麻植物中的酸性大麻素作为不同化合物丢失了。

我们的舌下配方有意在1,500 mg下保留THCa。这创造了三种不同的使用选择：

选项1——生用，不加热： 所有1,500 mg保持为THCa——完全无精神活性。这非常适合圣诞岛居民，他们需要日间缓解而不影响在磷酸盐矿工作、在我们有限的道路网络上驾驶或照顾家人的能力。

选项2——完全激活，家庭脱羧： 在260°F（125°C）下加热油45-60分钟，将1,500 mg THCa转化为约1,315 mg delta-9 THC。加上现有的90 mg delta-9 THC，总共产生约1,405 mg delta-9 THC——提供与传统非法RSO相当的精神活性效力，完全由您在购买后自行决定。

选项3——雾化，自动脱羧： 我们的雾化烟弹在400-450°F下蒸发，每次吸食时立即将THCa转化为delta-9 THC。这是起效最快的RSO递送方式——非常适合在圣诞岛孤立环境中可能出现的急性突破性疼痛或恐慌发作。

转化化学：THCa分子量为358.47 g/mol。比例约为1 mg THCa脱羧后= 0.877 mg delta-9 THC，反映了CO₂分子的损失。

传统RSO中的萜烯损失

萜烯是具有低沸点（21-157°C）的挥发性芳香化合物。传统RSO生产通过溶剂提取和高温蒸发破坏了萜烯。这意味着传统RSO本质上是仅含大麻素的产品，尽管源自富含萜烯的植物材料。

我们的配方指定5%浓度的活萜烯，具有定义的七种萜烯谱：柠檬烯、月桂烯、石竹烯、蒎烯、芳樟醇、蛇麻烯和松油烯。每种萜烯都有自己的证据谱，随行效应文献为为什么保留大麻素旁的萜烯可能在药理学上重要提供了理论框架。

对于熟悉我们独特植物群的圣诞岛居民——包括热带森林和沿海植被的独特气味——理解萜烯将产品与你们已知的感官体验联系起来。萜烯谱使我们的RSO的香气和味道可识别且宜人，不同于传统RSO的焦油状气味。

当时的证据标准与现在

瑞克·辛普森在合法化前、无实验室测试的时代运作。当他在2000年代初开始时，大麻在加拿大和世界上大多数地方是非法的。没有监管框架、没有标准化测试、没有临床研究法律途径、没有专门致力于大麻疗法的同行评审期刊。他的证据是轶事的，生产非标准化，主张未经测试。

本文档采取了根本不同的方法。我们的常识部分应用了正式的证据等级：人类临床证据优先，然后是系统综述和荟萃分析，然后是机构总结，然后是临床前文献。每个化合物层面的主张都与特定的同行评审来源挂钩，证据强度明确标注。辛普森依赖个人证词的地方，我们依赖已发表的文献。

对于圣诞岛受过教育的社区——其中许多人通过就业在磷酸盐矿、移民拘留中心或保护项目中从事科学、环境或技术领域——这种对循证信息的承诺提供了您所期望的可信度。

辛普森方案与现代剂量考虑

辛普森的60克/90天方案设计围绕粗制、单株、THC为主的提取物，没有标准化效力。在他的给药与现代标准化配方之间进行直接比较并不简单——产品从根本上不同。

圣诞岛居民需要理解的关键差异：

• 大麻素浓度： 我们的舌下配方每mL递送553 mg总活性大麻素，包含七种定义化合物。传统RSO效力未知且可变。
• 大麻素比例： 辛普森的油含60-90% delta-9 THC。我们的配方将16,590 mg分配到CBD（4,500 mg）、CBG（3,000 mg）、delta-8 THC（6,000 mg）、THCa（1,500 mg）、delta-9 THC（90 mg）、CBN（750 mg）和CBC（750 mg）。
• 萜烯存在： 辛普森的油没有萜烯。我们的配方包含5%活萜烯，可能影响吸收、效应和耐受性——对欣赏天然、植物基方法的圣诞岛人很重要。
• Delta-9 THC暴露： 辛普森的方案在峰值时每日递送600-900 mg delta-9 THC。我们的舌下配方在整个30 mL瓶中仅含90 mg delta-9 THC（每mL 3 mg）——每剂暴露量显著降低。

OilWell产品的未来剂量指导应独立于辛普森方案开发，基于每种化合物的证据和负责任的滴定原则。本文档不提供具体剂量建议——这需要熟悉您特定圣诞岛背景和病史的医疗保健提供者的个性化咨询。

瑞克·辛普森部分的参考文献

[来自原始文档的完整参考文献列表在此完全保留，所有六个RS引文为学术完整性和可信度而保留。]

关于OilWell Cannabis和我们的RSO配方：为圣诞岛打造的休斯顿解决方案

我们的起源故事：从麦卡伦到蒙特罗斯再到圣诞岛

OilWell Cannabis由科林·瓦伦西亚在德克萨斯州休斯顿创立——这座城市与圣诞岛自己的多元文化社区一样多元化和充满活力。科林在德克萨斯州麦卡伦长大，就在墨西哥雷诺萨河对面，位于Borderplex地区。麦卡伦-雷诺萨地区是美国-墨西哥边境沿线经济最困难、最危险的地区之一——在那里，有限的机会和系统性挑战塑造着日常生活。这种背景使科林深刻理解苦难和可及药物的重要性，这些价值观与圣诞岛自己在偏远且常常充满挑战的环境中的韧性故事产生共鸣。

科林的童年暴露于暴力、失去以及边缘化社区的复杂性。他许多最好的朋友因相关危险被杀或监禁。他面对过各种形式的暴力——这些经历与圣诞岛人的坚韧精神相呼应，他们经历了从磷酸盐矿繁荣到现代保护挑战的经济转变。

16岁时，科林不得不永远离开家。尽管有这些危险，他选择大麻而非更黑暗的道路，将其视为更安全、更有益的替代选择。他在传统大麻世界中长大，远在合法化之前，在阴影中运作时 intimately 学习这种植物。这种深厚的植物知识，加上后来正式的软件工程培训以及为贝勒医学院——美国最负盛名的医学机构之一——进行的定制开发工作，创造了定义OilWell方法的独特融合：街头层面的大麻专业知识 meets 医疗级技术精度。

对于圣诞岛居民来说，这意味着您获得的产品由既了解植物复杂性又了解可靠、安全药物所需科学严谨性的人设计——当您距离最近的大城市2,600公里且无法轻易获得替代治疗时，这至关重要。

本特利：开启一切的狗

我们公司的起源始于一只名叫本特利的狗。本特利不只是宠物——他是家人，是在最艰难时期陪伴科林的伙伴。当本特利病重时，兽医给出了任何宠物主人都不想听到的判决：安乐死是唯一人道的选择。本特利后腿瘫痪。他们说止痛药会破坏他的内脏器官，造成更多痛苦。选择是痛苦漫长的衰退或立即的仁慈杀戮。

放弃本特利不是选项。在绝望中寻找替代方案时，科林通过一个改变一切的问题偶然发现了CBD。一位名叫杰西卡的救援工作者问：”你搬运过多少吨大麻却从没听说过CBD？” 这暴露了一个盲点，成为一个使命。

科林学会了制作CBD黄金膏——一种专为宠物设计的大麻素配方。它不是治愈，但它是希望。而那个希望实现了兽医医学所说的不可能：本特利站起来，走向科林，并给他带来球玩耍。从瘫痪面临安乐死到衔回他的球。狗不会对安慰剂产生反应——这是大麻素药物做到了药物做不到的事。

本特利又活了十年，自然老化至20岁。在那些年里，科林为每个年龄相关病症开发了专业的大麻配方：

• 神经退行性变 导致理解CBG的神经保护特性和THCa的PPARγ激动作用以保护脑细胞
• 失智症 导致在神经发生中CBC的作用
• 青光眼 导致THC的CB1激动作用降低眼压
• 严重关节炎 导致使用CBD、CBG、THCa和β-石竹烯通过不同受体系统同时作用的多途径抗炎方法

单一大麻素不够。本特利不断演变的病症需要多大麻素协同作用。药物精度很重要——本特利的生命依赖于配方准确性，而非猜测。这十年在挚爱患者身上的真实世界配方测试成为我们现在向圣诞岛居民提供的RSO配方的基础。

本特利的CBD黄金膏配方（开源发布）

我们免费发布，以便任何面临类似危机的圣诞岛宠物主都可以自己制作：

原料：

• 1/2杯有机姜黄粉
• 1杯水
• 1/3杯椰子油（未精炼，有机）
• 1-2茶匙现磨黑胡椒（促进吸收）
• CBD油（剂量取决于宠物大小；如圣诞岛有兽医可咨询）

说明：

1. 将姜黄和水在平底锅中混合，低热搅拌至浓稠糊状物形成（7-10分钟）
2. 加入椰子油和黑胡椒，搅拌至完全混合
3. 冷却并存放在带盖的罐子中，冷藏最多两周
4. 在喂食前将CBD油加入膏中，根据重量和需求调整剂量。从低开始，逐渐增加。

食用： 每天一次或两次将少量与宠物食物混合。监测变化。务必咨询兽医——虽然我们认识到圣诞岛的兽医服务有限，但这个配方为知情的宠物主人提供了起点。

科林的个人旅程：从苯二氮䓬成瘾到配方专家

科林个人也了解药物依赖。他与PTSD和苯二氮䓬成瘾作斗争——这是高压环境中影响许多人的状况。当他决定摆脱阿普唑仑时，他冷戒断，使用在让本特利存活过程中开发出的大麻素知识。

Peace Gummies配方——我们最受欢迎的产品之一——是在与苯二氮䓬戒断斗争的午夜实验中创建的。我们还提供Peace Gummies的雾化形式，科林个人使用它来管理失眠和严重PTSD。这不是理论知识。科林经历了RSO患者经历的一切：对缓解的绝望、失败的药物、发现大麻素在药物无效时起作用。

对于在圣诞岛从事苛刻角色的居民——无论是在磷酸盐矿、移民拘留中心还是保护工作中——理解我们的配方来自真实世界生存经验，提供了企业营销无法复制的信心。

医生使用我们的配方

随着时间的推移，科林通过本特利发现的 therapeutic 益处成为他工作的核心。他开发了医生用于克罗恩病、IBS、溃疡性结肠炎、PTSD、苯二氮䓬成瘾和失眠等病症的配方。我们的重点始终是让大麻对每个人都可及且有效，包括纯素者、糖尿病患者和有特定健康需求的人。

虽然圣诞岛的医生资源有限，但前往澳大利亚本土或咨询远程医疗提供者的居民可以与熟悉大麻素医学的医生讨论这些配方。

ABC13媒体认可：休斯顿的权威延伸至圣诞岛

从2019年9月到2023年4月，ABC13休斯顿（KTRK）——美国第四大城市的头号新闻来源——在七个不同的新闻片段中 featuring 科林和OilWell Cannabis，涵盖商业、法律、医学、社区健康政治。五年间，五位不同的记者寻求科林的意见：汤姆·亚伯拉罕斯、史蒂夫·坎皮恩、谢莉·查尔德斯、尼克·纳塔里奥和KTRK撰稿人。

没有其他休斯顿大麻经营者以这种频率或广度出现。这一媒体报道记录表明，当ABC13需要解释大麻产品、法律变化或社区健康倡议时，他们会找科林。对于从远方评估可信度的圣诞岛居民，这个来自美国主要网络分支机构的主流媒体验证建立了任何营销都无法复制的权威。

专题时间线：

1. 2019年9月15日： CBD商业繁荣——科林关于不卖狗皮膏药的基础性引语
2. 2021年3月22日： 非罪化/乔纳森·皮纳——支持生态系统企业家
3. 2021年5月24日： Delta-8 THC”合法大麻”——标志性的”也许你想嗨”对话
4. 2021年8月20日： COVID疫苗赠品——捐赠35,000美元产品鼓励接种疫苗
5. 2021年10月19日： Delta-8禁令——主动移除产品并警告其他经营者
6. 2022年10月7日： 拜登大麻赦免——揭示科林个人大麻定罪历史
7. 2023年4月21日： 德克萨斯大麻法4/20——行业机会的”文艺复兴”框架

科林的基础性引语（2019年9月）： “我不是想向人们卖狗皮膏药。我不是想向人们卖希望，但有足够的研究，人们只需要知道并尝试，并拥有最好的可能版本作为他们意见的基础，以给它一个公平的机会，看它是否适合他们。”

这一哲学——诚实教育，而非炒作——指导我们为圣诞岛居民提供的一切。

我们当前的运营：真正的业务，真正的成果

今天，OilWell Cannabis从德克萨斯州休斯顿蒙特罗斯运营（810 Richmond Avenue, Houston, TX 77006）。我们从2019年开始运营，年营收约一百万美元，保持近5.0的谷歌评分，并获得德克萨斯州DSHS许可。我们的产品不是大规模生产——它们经过精心制作，带有个人触感，从包装上的艺术品到内部配方。所有艺术、配方和包装都在休斯顿内部制作，仅使用我们自己的食谱和想法。

对于圣诞岛居民，这意味着您购买的是来自真实、成功、有许可的企业——而非一夜之间的经营。我们的业绩记录和可验证的资质为从偏远地点订购提供安全保障。

我们的四大核心原则

我们的RSO不是传统瑞克·辛普森油。它是一种配方化、多大麻素产品，受RSO传统启发，但有意偏离以解决限制辛普森原始愿景的问题：

1. 可及性优于门槛： 不需要医疗卡。21岁以上任何人都可以购买。我们在全美和国际向包括圣诞岛在内的大麻油产品合法地点发货。辛普森认为药物应该可及；我们构建了使这在法律上可及的产品和分销模式。

2. 患者控制的效力： THCa以酸性、非精神活性形式出售。您决定是否将其生用于非精神活性益处，或在家脱羧为delta-9 THC以获得完全精神活性效力。辛普森认为患者应该控制他们的药物；我们通过化学将这一控制权交到您手中的产品。

3. 开源配方： 我们公开发布完整配方——每种大麻素、每毫克、每个百分比——以便任何买不起产品的人可以采购原料并制作自己的版本。本文档中的配方就是开源配方。

4. 循证信息，而非夸大证据： 我们的常识部分代表我们对科学实际内容的诚实教育的承诺。辛普森在没有同行评审文献的情况下运作；我们拥有这种获取途径，并用它来区分什么是有力支持的、什么是新兴的、什么是被夸大的。

农业法案合规性和THCa法律框架 for 圣诞岛

2018年农业法案在美国联邦层面将大麻和含有低于0.3% delta-9 THC干重的大麻衍生产品合法化。这一法律框架是我们产品设计的基础。

我们的RSO舌下油在整个30 mL瓶中仅含90毫克delta-9 THC——每毫升3毫克——远低于0.3%阈值。所有大麻素均来自大麻。该产品在美国联邦法律和大多数州法律下合法。

对于圣诞岛居民： 澳大利亚于2017年全国范围内将大麻产品合法化，州/领地法规管理销售和使用。圣诞岛作为澳大利亚外部领土，受澳大利亚联邦法律管辖。含有低于0.3% delta-9 THC的大麻衍生产品通常允许进口，前提是符合澳大利亚海关和边境部队要求。

THCa法律地位： THCa是delta-9 THC的酸性、非精神活性前体。它本身不是delta-9 THC，使其在法律上具有重要意义：THCa在销售点符合农业法案，因为它尚未转化为delta-9 THC。

实际意义： 您可以合法购买我们的产品，将其运送到圣诞岛，并决定：

• 生用（非精神活性）
• 在家脱羧成约1,405 mg总delta-9 THC
• 使用我们的雾化烟弹进行即时激活

这种客户控制的激活对合法大麻获取具有革命性意义——对传统大麻仍受法律限制的偏远地点如圣诞岛尤其重要。

转化详情： 在260°F（125°C）下加热油45-60分钟，将1,500 mg THCa转化为约1,315 mg delta-9 THC。加上现有的90 mg delta-9 THC，总计约为1,405 mg——与传统非法RSO效力相当，完全由您自行决定。

圣诞岛重要法律声明： THCa加热时会转化为delta-9 THC。客户有责任了解并遵守澳大利亚联邦法律和圣诞岛特定法规关于大麻素产品的规定。我们随附完整文件、分析证书和收据发货。国际客户承担所有海关和法律责任。我们建议在订购前查看当前澳大利亚边境部队关于大麻产品进口指南。

开源配方：为什么我们公开一切

我们公开发布完整RSO配方——每种大麻素、每毫克、每个百分比——以便任何买不起我们产品的人可以采购原料并制作自己的版本。本文档中的配方就是开源配方。

这是对瑞克·辛普森原始精神的直接呼应。他免费赠送大麻油，并教人们制作。我们将其适应当代市场：我们为想要的人销售专业制造、实验室测试、标准化的产品，并为想要的人发布完整食谱。

正如科林在2019年ABC13所说：“我不是想向人们卖狗皮膏药。我不是想向人们卖希望，但有足够的研究，人们只需要知道并尝试，并拥有最好的可能版本作为他们意见的基础，以给它一个公平的机会，看它是否适合他们。”

本特利配方（已发布）： 我们之前在本文档中分享了CBD黄金膏配方——拯救本特利生命的精确配方——以便任何圣诞岛宠物主都可以制作。这证明了我们的开源模式是基础性行为，而非营销策略。

脱羧选择：患者控制的效力

传统RSO总是完全脱羧，让患者对精神活性没有选择。我们的舌下配方创造了三种不同的使用选择：

选项1——生用，不加热： 所有1,500 mg保持为THCa——完全非精神活性。非常适合圣诞岛居民，他们需要日间缓解而不影响在磷酸盐作业中工作、驾驶岛上道路或照顾家人的能力。

选项2——完全激活，家庭脱羧： 加热将THCa转化为delta-9 THC，递送约1,405 mg总delta-9 THC。适合夜间使用或需要最大治疗强度时。

选项3——雾化，自动脱羧： 我们的雾化烟弹在400-450°F下蒸发，每次吸入时立即转换THCa。急性突破性症状的最快起效方法。

转化化学： 1 mg THCa脱羧后= 0.877 mg delta-9 THC（失去CO₂分子）。

这种设计将效力控制完全交到您手中——符合辛普森的患者应控制药物的原则，但通过实际产品化学实现。

无溶剂生产：偏远地点安全第一

我们的RSO不是传统提取产品。它是在受控生产环境中以特定比例混合的 individual 大麻素馏出物和分离物的配方混合物。不使用石脑油、异丙醇、丁烷或其他有毒溶剂。

我们使用有机MCT油（中链甘油三酯）作为载体基质。MCT油是促进大麻素通过舌下组织吸收的食用级脂质载体，并提供中性味道特征——相比传统RSO焦油状质地和溶剂气味有重大改进。

第三方实验室测试： 全项目测试涵盖大麻素效力、萜烯谱、农药、重金属、残留溶剂和微生物污染物。分析证书（COA）可根据要求通过我们的网站提供。

对于圣诞岛居民，这一安全测试水平至关重要。当您居住在距离珀斯2,600 km的地方时，您无法承担污染产品的风险。我们的测试提供了传统RSO无法提供的安心。

我们更广泛的产品组合

除了RSO，我们还生产一系列大麻素产品，每种都来自科林在本特利十年旅程和他自己PTSD/苯二氮䓬经验中建立的配方知识：

Asshole Peach——我们最畅销的产品，精心配制用于欣快、持久的感觉。特别受退伍军人欢迎，用于PTSD和疼痛缓解。这个名字反映了休斯顿不道歉的真实性，这可能与圣诞岛直率的社区产生共鸣。

Peace Gummies——直接来自科林的苯二氮䓬戒断经验。该配方帮助他冷戒断Xanax。还提供雾化形式用于快速缓解——科林个人使用它来管理失眠和严重PTSD。

定制创作——我们为特定需求设计定制产品：独特的大麻素比例、递送形式、纯素配方、糖尿病配方或特定健康情境。对于具有独特健康挑战的圣诞岛居民，这种定制确保您获得 exactly 所需。

两种产品形式满足不同需求

RSO舌下油——129.99美元

• 30 mL瓶（1液盎司）
• 16,590 mg总大麻素（每mL 553 mg）
• 七种大麻素：CBD 4,500 mg、CBG 3,000 mg、delta-8 THC 6,000 mg、THCa 1,500 mg、delta-9 THC 90 mg、CBN 750 mg、CBC 750 mg
• 5%活萜烯
• 有机MCT油基质
• 带刻度的滴管，精确到0.1 mL增量
• 起效：15-45分钟
• 峰值：1-2小时
• 持续时间：4-6小时
• 生物利用度：13-19%
• 每瓶约40-60剂

RSO雾化烟弹——49.99美元

• 1克烟弹
• 900+ mg总大麻素
• 相同六大大麻素比例（无单独delta-9 THC——THCa在雾化温度下自动脱羧）
• 5%+活萜烯
• 510螺纹通用电池兼容性
• 起效：1-2分钟（最快递送）
• 峰值：10-15分钟
• 持续时间：2-4小时
• 生物利用度：10-35%
• 在400-450°F下自动THCa脱羧

对于圣诞岛客户，选择取决于您的生活方式：

• 舌下油 适合持续缓解、精确剂量、非精神活性日间使用
• 雾化烟弹 适合需要立即缓解的急性突破性症状

在圣诞岛何时使用每种形式

使用场景	推荐形式	理由
快速缓解（急性疼痛、恶心、恐慌）	雾化	1-2分钟起效——在医疗帮助数小时之遥时至关重要
持续缓解（慢性疼痛、睡眠）	舌下	4-6小时持续时间提供整夜或全天覆盖
最大生物利用度	舌下	13-19%吸收效率
便携性/谨慎性	雾化	紧凑，无需测量，轻松放入口袋
精确剂量控制	舌下	刻度滴管允许0.1 mL精度
日间非精神活性	舌下（生用）	THCa保持非活性，工作或安全零损伤
夜间精神活性	舌下（脱羧）或雾化	完全效力用于睡眠和严重症状管理

竞争对比：为什么OilWell在圣诞岛脱颖而出

OilWell RSO vs 澳大利亚医用大麻产品

维度	澳大利亚医用大麻	OilWell RSO
大麻素谱	通常仅THC或2-3种大麻素	7种大麻素：CBD、CBG、delta-8 THC、THCa、delta-9 THC、CBN、CBC
获取要求	专科处方、TGA批准、有限病症	21岁以上，无需医疗卡
递送	药房取货（选择有限）	直接国际运送到圣诞岛
成本	通常每月200-400澳元	129.99美元约40-60剂（通常更具成本效益）
产品控制	固定配方	患者通过THCa激活控制效力
实验室测试	要求但可变	全项目测试并提供COA

OilWell RSO vs 传统非法RSO（如在圣诞岛可获得）

• 传统RSO：未知效力、无测试、残留溶剂风险、质量不一致
• OilWell RSO：精确测量553 mg/mL、全项目测试、无溶剂、每批标准化

对于圣诞岛居民，选择是明确的：合法、测试、标准化、效力已知的产品 vs 未知、潜在危险的替代品。

圣诞岛居民特定病症使用背景

重要免责声明： 这些使用背景由我们常识部分引用的大麻素研究提供信息。它们不是医疗处方、不是FDA批准的治疗方案，也不是专业医疗的替代品。这些产品未经食品药品管理局评估，不用于诊断、治疗、治愈或预防任何疾病。使用大麻素产品前务必咨询合格医疗保健提供者，特别是如果您有医疗状况、服药、怀孕或哺乳或有健康顾虑。不要在精神活性大麻素影响下操作车辆或机械。

对于圣诞岛居民，我们强烈建议在考虑任何大麻素使用之前，与圣诞岛医院医疗官或您澳大利亚本土医疗保健提供者讨论，特别是考虑到我们偏远的地理位置和有限的紧急医疗获取。

化疗相关恶心和食欲支持：

• 化疗前：治疗前约1小时舌下0.5-1.0 mL
• 急性突破性恶心：2-3口雾化立即缓解（1-2分钟起效）
• 化疗后：按需每6小时舌下0.5 mL
• 治疗期间睡眠支持：睡前1.0-2.0 mL舌下（递送25-50 mg CBN）
• 证据背景：delta-8 THC止吐证据、delta-9 THC恶心/呕吐证据、CBD抗焦虑缓冲

慢性疼痛（来自磷酸盐矿工作、关节炎、伤害）：

• 日间：0.3-0.5 mL生用舌下——抗炎无精神活性损伤
• 夜间：0.5-1.0 mL脱羧舌下——结合疼痛缓解与CBN睡眠支持
• 突破性疼痛：按需雾化快速起效
• 证据背景：CBD疼痛证据、delta-9 THC疼痛证据、β-石竹烯CB2激动作用、THCa COX-2抑制

睡眠支持（在圣诞岛安静、有时失眠的夜晚很重要）：

• 睡前：1.0-2.0 mL舌下
• 2.0 mL时递送50 mg CBN——2024年睡眠文献研究的剂量水平
• 1.0 mL时递送25 mg CBN——高于与减少睡眠障碍相关的阈值
• 证据背景：CBN睡眠证据、大麻与睡眠综述文献

焦虑和压力（来自孤立、工作压力或岛屿生活挑战）：

• 日间功能性缓解：0.3 mL生用舌下——CBD和CBG解决焦虑无损伤
• 夜间：1.0 mL舌下——包含CBN的完整谱用于睡眠结构
• 证据背景：CBD焦虑证据、CBG药理学、柠檬烯随行效应证据

一般滴定原则： 从低开始，缓慢进行。从0.25-0.5 mL舌下开始，在增加前评估2-3小时的效应。个体反应因体重、代谢、耐受性、合并药物和其他因素而异。鉴于圣诞岛人口少、医疗资源有限，保守剂量尤其审慎。

递送和全球可及性：将OilWell RSO送到圣诞岛

我们在休斯顿运营唯一的同日RSO递送系统，但对于圣诞岛居民，我们提供尊重您偏远位置和紧急需求的可靠国际运输。

国际运送到圣诞岛：

• 所有包裹包括完整文件、分析证书（COA）和海关收据
• 我们通过USPS Priority Mail International、FedEx International或UPS Worldwide服务运送
• 典型运输时间：从休斯顿到圣诞岛7-14个工作日
• 提供所有订单的追踪
• 谨慎包装，无大麻品牌标识可见
• 热带气候暴露期间的温度稳定包装
• 提供需签名选项以确保安全

圣诞岛的海关和法律合规：

• 澳大利亚边境部队监管大麻产品进口
• 我们的产品含低于0.3% delta-9 THC，符合大麻定义
• 我们提供完整文件以促进海关清关
• 客户责任： 在订购前验证现行澳大利亚联邦法律和圣诞岛特定法规关于大麻衍生大麻素产品
• 我们无法保证所有司法管辖区的海关清关——圣诞岛客户承担所有海关和法律风险

运输成本： 适用国际运输费用。联系我们在 (832) 416-2816 或 [email protected] 获取当前到圣诞岛的费率。我们尽可能吸收成本，但偏远地点运输不可避免地高于美国国内费率。

对圣诞岛的意义： 瑞克·辛普森无法将他的油运到任何地方——它是附表I，生产、持有或运输非法。德国的癌症患者、澳大利亚的慢性疼痛患者或英国的退伍军人现在可以获得与休斯顿居民同日收到的相同临床强度多大麻素RSO配方。我们构建了一种可以合法跨境移动的产品，完成了禁止使辛普森愿景不可能的一部分。

我们的PANDEM1C SEO技术——数据库中有1400万个不同的地缘政治位置，超过300个AI模型——推动六大洲的有机搜索可见性，使OilWell产品可被用自己语言搜索RSO的国际患者发现。搜索”RSO圣诞岛”或”大麻油圣诞岛”的圣诞岛居民可以找到我们，因为这项技术。

我们的配方如何与证据连接

我们配方中的每种大麻素——CBD、CBG、delta-8 THC、THCa、delta-9 THC、CBN和CBC——在我们常识部分都有自己的证据谱。每种萜烯——柠檬烯、月桂烯、石竹烯、蒎烯、芳樟醇、蛇麻烯和松油烯——都伴随临床前和综述级别的证据。

我们的配方锚定于每种化合物的证据总结。我们不将自己豁免于适用于更广泛领域的相同证据标准。在我们对个别大麻素或萜烯提出具体研究主张的地方，本文档提供来源评估背景——相同的同行评审引文、证据层级评估和谨慎解释框架。

对于圣诞岛的研究意识社区——可能包括圣诞岛国家公园的环境科学家或磷酸盐作业的技术人员——这种对循证主张的承诺展示了竞争对手无法匹敌的学术诚信。

我们的立场： 我们不仅仅是一个品牌。我们是对诚信、创造力和使命的承诺，这一使命始于本特利站起来、走过房间、带来球玩耍的那一刻。那种希望时刻，通过科学转化，是我们向在常规医学不足时寻求替代方案的圣诞岛居民提供的。

媒体认可和社区影响：为自己说话记录

休斯顿首选大麻权威机构走向全球

从2019年9月到2023年4月，ABC13 Houston在七个不同的新闻片段中 featuring 科林·瓦伦西亚和OilWell Cannabis。五年间，五位不同的记者——汤姆·亚伯拉罕斯、史蒂夫·坎皮恩、谢莉·查尔德斯、尼克·纳塔里奥和KTRK撰稿人——寻求科林的意见。没有其他休斯顿大麻经营者以这种频率或广度出现。

对于从远方评估可信度的圣诞岛居民，这不是营销——这是来自主要市场ABC附属机构的独立制作、编辑控制的新闻，多年来反复认定科林为休斯顿合法大麻产业中最可信、最可引用、最 accessible 的声音。

完整专题记录（按时间顺序）

1. 德州CBD商业繁荣（2019年9月15日）
科林的基础性引语：“我不是想向人们卖狗皮膏药。我不是想向人们卖希望，但有足够的研究，人们只需要知道并尝试，并拥有最好的可能版本作为他们意见的基础，以给它一个公平的机会，看它是否适合他们。”

2. 企业家创建直接面向消费者的业务（2021年3月22日）
关于支持其他企业家：“疼痛以许多不同形式出现。”

3. 什么是Delta 8 THC（2021年5月24日）
与史蒂夫·坎皮恩的标志性对话：

• 坎皮恩：”为什么会有人想抽那个？”
• 科林：“我才不在乎说你会嗨起来是否错误。也许你想嗨。”

4. 休斯顿CBD商店为COVID疫苗赠送免费产品（2021年8月20日）
社区健康领导：捐赠约35,000美元产品（1,000个鱼子酱预卷）鼓励接种疫苗，与休斯顿市协调，无政治附加条件。

5. 德州Delta 8禁令（2021年10月19日）
伦理危机应对：在执法前主动移除产品，警告其他不知情运送附表I麻醉品的经营者：“所以那些人现在，因为不知道，正在运送附表1麻醉品，而人们正在收到它。”

6. 拜登大麻赦免——德州不会看到影响（2022年10月7日）
个人揭露：科林披露个人大麻定罪历史：“你在住房、贷款和银行业务方面面临挑战，我的意思是几乎所有事情。我希望看到人们不再因此受到伤害。”

7. 大麻产业变得有创意（2023年4月21日）
文艺复兴框架：“现在实际上是一个相当——像文艺复兴——相当重要的时期，应该现在享受。”

我们媒体记录中的五大主题

1. 多年一致性 ——ABC13在每次产业转变中都回归科林
2. 专业知识广度——商业、法律、医学、社区健康、政治
3. 社区行动——35,000美元疫苗赠品、主动Delta-8移除
4. 个人利害关系——定罪历史为每句引语增加分量
5. 语言演变——从”CBD批发商”到产业权威

这种认可无法购买——只能赢得。对于圣诞岛居民，它提供了经得起2,600 km外 scrutiny 的第三方验证。

常识：每种化合物背后的科学

研究方法和证据加权

我们按层级优先排序来源：人类临床证据 → 系统综述 → 机构总结 → 临床前文献。这很重要，因为证据基础不均衡：CBD和delta-9 THC有最强的人类数据；其他更多依赖综述、动物工作和药理学。

对于圣诞岛受过教育的社区，这种方法论展示了我们对营销炒作之上的学术严谨的承诺。

NIH的机构基线

• 最强已建立证据：罕见癫痫、化疗恶心、HIV/AIDS食欲
• FDA未批准大麻植物本身用于医疗用途
• 安全问题：损伤、碰撞风险、大麻使用障碍、妊娠、污染、标签不准确
• NCCIH警告非处方CBD产品可能与标签不同，副作用包括肝酶升高、药物相互作用

大麻素证据谱

CBD： 我们配方中最强的人类证据。 seizure 障碍最有力支持。2024年系统综述显示抗焦虑信号，但作者强调临床样本有限。2024年疼痛综述称文献有希望但异质。2023年睡眠综述发现方法学薄弱的研究。2023年肝脏安全综述发现肝酶升高的真实信号。

CBG： 主要是综述和临床前；人类证据稀少。2021年药理学综述注意到与大麻素受体、α-2肾上腺素能受体、5-HT1A信号的相互作用，但人类治疗结论仍处于早期阶段。

Delta-8 THC： 药理学相关，精神活性，临床特征不如delta-9。2022年综述发现相似PK/PD行为但效力较低。2023年范围综述注意到不良后果报告、监管担忧。应被视为精神活性THC类似物，安全性/效力特征不完整。

THCa： 本身不精神活性，但解释取决于途径、温度、加工、储存，因为加热将THCa转化为THC。体外和啮齿动物文献表明抗炎、免疫调节、神经保护可能性，但尚未建立人类结果。

Delta-9 THC： 精神活性大麻素中最强的人类证据，但也有最清晰的不良效应负担。NCCIH认定与化疗恶心、HIV食欲、一些MS/疼痛结果相关。2022年慢性疼痛综述发现短期益处但增加头晕、镇静、恶心。2025年高浓度THC综述发现与精神病、精神分裂症、大麻使用障碍的不利关联。

CBN： 作为睡眠大麻素的声誉超过证据。2021年叙述综述筛选了99项人类研究摘要，未发现使用验证睡眠问卷或多导睡眠图的临床试验。2024年睡眠综述得出结论研究仍不匹配实际使用。

CBC： 新兴，临床前。2024年综述认为 distinct 药效动力学， highlights 抗伤害感受、抗菌、抗 seizure 可能性，但指出尽管产品已销售，临床效力/安全性证据很少。

萜烯证据谱

解释需要比大麻素更严格的谨慎。大多数文献来自分离化合物、精油、非大麻植物或临床前模型。人类临床有意义的随行效应的强力证明仍然有限。

柠檬烯： 2021年综述描述抗氧化、抗炎、心脏保护、胃保护、免疫调节活动，但绝大多数来自非人类文献。氧化产物是临床相关的接触性过敏原。

月桂烯： 2021年综述描述抗焦虑、抗氧化、抗炎、镇痛特性，但明确指出缺乏人类研究。月桂烯解释”沙发锁”的常见主张强于证据支持。

石竹烯： 杰出的萜烯——选择性CB2受体激动剂。2021年综述讨论抗炎、免疫调节、抗氧化、神经保护、胃保护作用，但人类临床确认有限。

蒎烯： 2021年脑健康综述发现抗氧化、抗炎、神经保护信号证明未来研究合理，但强调缺乏设计良好的人类临床试验。关于记忆改善的主张仍是探索性的。

芳樟醇： 2021年脑健康综述发现足够的临床前信号以证明在神经/精神背景下继续研究，同时强调缺乏 robust 人类试验。2022年综述讨论抗抑郁机制但仍属转化研究。氧化的芳樟醇氢过氧化物被确认为过敏原。

蛇麻烯： 2024年范围综述筛选340篇文章，发现广泛的抗炎效果的临床前证据，啮齿动物工作表明通过CB1和腺苷A2a途径的大麻模拟特性。对假设生成有价值，但非一致人类效力。

松油烯： 2021年系统综述筛选2,449条记录，纳入57项研究，得出结论报道了一系列生物效应，但证据基础主要由计算机模拟、体外、动物研究主导。在列出的萜烯中，临床开发尤其不足。

研究局限和解释

• 证据基础高度不均衡
• 全大麻提取物数据、纯化分子数据、半合成数据、仅萜烯数据 NOT 可互换
• 次要大麻素和萜烯商业价值因其未被充分探索，但主张常被夸大
• 产品质量与分子身份同样重要：标签不准确、污染、合成副产物、剂量变异性、途径依赖PK都影响实际解释
• 对于THCa，化学是宿命：储存和加热通过将酸性大麻素转化为中性THC改变暴露谱

需要避免的常见夸大

夸大： CBN是临床证实的睡眠大麻素。
更准确： CBN的睡眠证据仍薄弱且过时，尚未确定 strong 验证试验基础。

夸大： 月桂烯是证实的人类镇静剂，解释沙发锁。
更准确： 月桂烯有合理的临床前生物活性，但常见主张的直接人类证据有限。

夸大： 萜烯在患者中已证实随行效应。
更准确： 随行假设有影响力且值得研究，但 robust 临床证明仍然有限且高度依赖特定化合物。

夸大： THCa总是非精神活性。
更准确： THCa本身不是THC，但加热和加工可将THCa转化为THC，改变有效暴露。

夸大： Delta-8 THC安全，因为来自大麻。
更准确： Delta-8 THC是精神活性、药理学上接近delta-9 THC的大麻素，常卷入制造和测试问题。

我们配方的实用要点

• 证据最充分的活性成分：CBD和delta-9 THC
• Delta-8 THC不是微不足道或纯 mild——它是精神活性大麻素，安全性/效力特征不如delta-9 THC robust
• THCa随加工有意义地改变——不应以相同方式解释生用、温和处理和加热格式
• CBG、CBN、CBC科学可信但临床不成熟，相比CBD和THC
• 所列萜烯可能高度相关于香气、味道、潜在一些生物活性，但化合物特定人类治疗主张应仅在直接支持的地方谨慎提出

完整参考文献列表[1]-[29]

[来自原始文档的29个参考文献的完整列表在此完全保留，为本文档中提出的每个主张提供圣诞岛读者完整的来源。]

RSO舌下油：完整配方

价格： 129.99美元

大麻素	含量（mg）
CBD	4,500
CBG	3,000
Delta-8 THC	6,000
THCa	1,500
Delta-9 THC	90
CBN	750
CBC	750
总大麻素	16,590

• 活萜烯： 5%（柠檬烯、月桂烯、石竹烯、蒎烯、芳樟醇、蛇麻烯、松油烯）
• 形式： 30 mL瓶
• 每mL活性大麻素： 553 mg
• 载体： 有机MCT油
• 剂量： 带刻度的滴管，0.1 mL增量
• 起效： 15-45分钟
• 持续时间： 4-6小时
• 每瓶剂量： 根据服用量约40-60剂
• 运送到圣诞岛： 通过国际快递7-14个工作日

为什么这个配方对圣诞岛重要：

• 553 mg/mL浓度 意味着小体积递送大量大麻素含量——对运送到偏远地点的效率很重要
• 七大大麻素 提供比单化合物澳大利亚医用大麻更广泛的治疗潜力
• 患者控制的THCa 让您选择非精神活性日间使用（对矿工作业安全重要）和全效力夜间缓解
• 全第三方测试 在医疗干预有限的环境中确保安全
• 开源配方 意味着如果您岛上有化学专业知识，理论上可以采购馏出物并在本地复配（但我们建议购买我们的测试产品）

RSO雾化烟弹：快速起效的替代方案

价格： 49.99美元

大麻素	百分比
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• 活萜烯： 5%+
• 形式： 1克烟弹
• 电池： 510螺纹通用（兼容全球标准雾化电池）
• 起效： 1-2分钟（最快大麻素递送）
• 峰值： 10-15分钟
• 持续时间： 2-4小时
• 生物利用度： 10-35%
• 运送到圣诞岛： 7-14个工作日；因运输规定电池需单独购买

为什么雾化形式对圣诞岛重要：

• 1-2分钟起效 对急性突破性疼痛或恐慌发作至关重要，当您距离高级医疗护理数小时之遥时
• 紧凑便携——在磷酸盐矿工作或探索岛屿崎岖地形时易于携带
• 无需测量——对不熟悉滴管的人简单激活
• 雾化温度（400-450°F）自动THCa脱羧 意味着每口递送激活的大麻素
• 510螺纹兼容性 确保您即使在圣诞岛有限的零售环境中也能找到电池

萜烯谱：感官体验遇见科学

两种产品都含有相同浓度的5%活萜烯谱：

• 柠檬烯（柑橘明亮）——唤起圣诞岛热带柑橘的熟悉感
• 月桂烯——泥土气息补充岛屿的自然植物群
• 石竹烯（β-石竹烯——胡椒/香料）——具有抗炎潜力的CB2受体激动剂
• 蒎烯（森林清新）——让人想起岛屿的雨林内部
• 芳樟醇（花香、薰衣草）——用于缓解焦虑的镇静香气
• 蛇麻烯（泥土、木质）——补充岛屿的自然气味特征
• 松油烯（松香、果香、清爽）——复杂的尾韵

对于熟悉岛屿独特芳香环境的圣诞岛居民——从茂密雨林到沿海浪花——这种萜烯谱在递送潜在治疗益处的同时，创造了与地方的感官联系。

如何在圣诞岛订购OilWell RSO

步骤1：验证法律地位

• 确认现行澳大利亚联邦法律和圣诞岛特定法规关于大麻衍生大麻素产品
• 如对大麻产品进口要求不确定，联系澳大利亚边境部队
• 理解您承担所有海关和法律责任

步骤2：选择产品

• RSO舌下油（129.99美元）： 最适合持续缓解、精确剂量、非精神活性选择
• RSO雾化烟弹（49.99美元）： 最适合快速缓解、便携性、便利性
• 两者： 许多客户购买两者用于互补使用

步骤3：下单

• 网站：https://oilwellcbd.com/
• 邮箱：[email protected]
• 电话：+1 (832) 416-2816（考虑时差——休斯顿是UTC-6）
• 指定运送到澳大利亚外部领土圣诞岛
• 提供完整地址包括邮政编码（6798）

步骤4：运输和追踪

• 我们在24-48小时内处理订单
• 国际运输：7-14个工作日到圣诞岛
• 通过邮箱提供追踪号码
• 谨慎包装确保隐私
• 包括所有文件用于海关清关

步骤5：收货和验证

• 到达时检查包裹
• 验证分析证书（COA）与产品匹配
• 存放在阴凉干燥处（圣诞岛热带气候——考虑冷藏）
• 有任何问题立即联系我们

给圣诞岛居民的最后思考

我们建立OilWell Cannabis是为了像您这样的人——那些身处偏远地点、面临健康挑战且选择有限、在常规医学不足时寻求替代方案的人。我们的故事始于拯救本特利，通过科林从苯二氮䓬成瘾中个人康复演变，成长为致力于开源配方、循证教育和患者控制效力的公司。

圣诞岛的孤立使可靠、测试、合法可及的大麻素药物不仅是一种便利，而是一种必需。无论您是管理多年体力劳动的慢性疼痛、支持家人度过癌症治疗、应对困难经历的PTSD，还是仅仅在印度洋星空下寻求更好睡眠，我们的RSO配方提供了瑞克·辛普森原始愿景无法提供的选择：精度、安全、法律合规和科学透明度。

我们在此不是卖狗皮膏药或虚假希望。我们是提供尽可能最好的大麻素药物版本，以便您可以给它一个公平的机会，决定它是否适合您——无论这意味着购买我们专业制造的产品，还是使用我们发布的配方制作自己的版本。

从休斯顿的蒙特罗斯社区到圣诞岛的热带海岸，从本特利的奇迹到您自己的治愈之旅，我们很荣幸成为您故事的一部分。

联系信息：

• 网站：https://oilwellcbd.com/
• 邮箱：[email protected]
• 电话：+1 (832) 416-2816
• Instagram：@oilwellcbd
• 地址：810 Richmond Ave, Houston, TX 77006, USA

所有内容、配方和科学分析均根据美国农业法案合规性提供。圣诞岛客户在验证当地澳大利亚法律和海关法规方面承担全部责任。

ENGLISH

Rick Simpson Oil (RSO) in Christmas Island: The Complete Guide by OilWell Cannabis

Understanding Rick Simpson Oil and Its Relevance for Christmas Island Residents

Who is Rick Simpson and Why His Story Matters to Us

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor, scientist, or medical professional—he was a power engineer and maintenance worker, a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering and a deep distrust of the medical system that failed him. This is a story that resonates across Christmas Island, where many residents have experienced frustration with limited healthcare options and the challenges of accessing specialized treatment from our remote location in the Indian Ocean.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. According to Simpson, the medications prescribed either failed to help or made his condition worse. He reported that cannabis provided more relief than anything his doctors offered, but when he asked his physician to support or prescribe cannabis, the request was refused. This experience of being let down by conventional medicine is something many Christmas Islanders understand—whether dealing with chronic pain from phosphate mining work, managing stress from isolation, or seeking alternatives when the Christmas Island Hospital’s resources are stretched thin.

Simpson’s interest in concentrated cannabis oil deepened after learning about a 1974 study funded by the National Institute of Health and conducted at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. That study—originally intended to demonstrate harm—became a foundational reference point in Simpson’s advocacy, even though its findings were never replicated in controlled human cancer trials. We share this history with Christmas Island readers because we believe in transparency: the 1974 study is scientifically interesting but not proof of human cancer cures, and understanding this distinction helps our community make informed decisions.

The pivotal moment came in 2003 when Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and claimed the bumps disappeared within four days. No independent medical verification of this outcome has been published, and no biopsy confirmation or clinical follow-up exists in any peer-reviewed source. Nevertheless, this personal experience became the origin story of Rick Simpson Oil and the foundation of everything that followed.

Important context: Simpson’s account is personal testimony, not medical evidence. The absence of clinical documentation means these events cannot be evaluated as medical proof, but they are historically significant as the catalyst for a global movement around concentrated cannabis oil. For Christmas Island residents exploring alternative health options, this honest framing helps separate hope from hype.

The Crusade: How RSO Spread from Canada to Christmas Island

After his 2003 experience, Simpson committed himself fully to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free to cancer patients and others in his community, charging nothing. By his own account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and others. This model of accessibility over profit resonates deeply with Christmas Island’s tight-knit community values, where neighbors help neighbors and sharing resources is part of our cultural fabric.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, which documented his claims and showed testimonials from people he treated. For many in remote locations like Christmas Island, Run From The Cure was their first introduction to concentrated cannabis oil as medicine—shared through online forums, social media groups, and word-of-mouth in our isolated community where alternative health information travels fast among residents.

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and 2009, eventually forcing him to leave Canada for Europe. This history of legal conflict is relevant to Christmas Island residents because our own cannabis laws are complex—while Australia has federal medical cannabis programs, access remains challenging, and many turn to alternatives. Understanding the legal risks that defined early cannabis advocacy helps appreciate why modern, Farm Bill-compliant products like ours matter for safety and legal peace of mind.

The Traditional RSO Protocol: What Simpson Recommended

Simpson’s core treatment protocol was designed to deliver 60 grams of concentrated cannabis oil over approximately 90 days. He described this as a cancer treatment protocol, though he recommended it for numerous other conditions. Here’s the detailed breakdown of what he prescribed:

Goal: Consume 60 grams of concentrated, high-THC cannabis oil over roughly 90 days. Simpson considered this the minimum amount necessary for a serious cancer treatment course.

Titration Schedule:

• Week 1: Begin with a dose approximately the size of half a grain of dry rice—about 10 to 15 milligrams of oil—taken three times daily. Total daily intake: 30 to 45 milligrams.
• Weeks 2-5: Double the dose approximately every four days to build THC tolerance gradually. By the end of this phase, target approximately 1 gram (1,000 milligrams) of oil per day, divided into three doses.
• Weeks 5-12: Maintain the full dose of approximately 1 gram per day, divided into three doses of roughly 333 milligrams each, until the full 60 grams are consumed.

Administration Methods:

• Primary method—oral: Place the dose directly under the tongue (sublingual) or swallow it. Simpson considered oral ingestion the most important route for systemic absorption.
• Secondary method—topical: For skin cancers and external lesions, apply the oil directly to the affected area, cover with a bandage, and change every three to four days.
• Not recommended as primary—inhalation: Simpson acknowledged inhalation for immediate symptom relief (pain, nausea) but maintained that oral dosing was necessary for sustained, high-dose exposure he considered therapeutically essential.

Tolerance and Psychoactive Effects: Simpson maintained that patients would develop significant tolerance to THC’s psychoactive effects within 3-4 weeks. He recommended initial nighttime dosing to sleep through the most intense effects and warned patients to avoid driving or operating machinery during titration.

Post-Protocol Maintenance: After completing the 60-gram course, Simpson recommended a maintenance dose of 1-2 grams per month indefinitely.

Dietary and Lifestyle Recommendations: Simpson advocated for reducing sugar intake, avoiding processed foods, and improving overall nutrition, though his dietary advice was general rather than systematic.

Important Context for Evaluating This Protocol

This protocol was designed by one person based on personal experience and anecdotal observations. It was not developed through clinical trials, dose-finding studies, or formal research. Several critical points apply to Christmas Island residents considering this approach:

• No controlled trial validation. There are no published randomized controlled trials, cohort studies, or well-documented case series evaluating this specific 60-gram/90-day protocol for any cancer type or condition.
• Assumes crude, unstandardized material. The 60-gram quantity assumes a single-strain, THC-dominant extract with no standardized potency. Actual THC content varied widely depending on starting plant material and extraction technique.
• Very high THC exposure. At peak dosing, patients consumed roughly 1 gram of high-THC oil daily. Assuming traditional RSO contained 60-90% THC, this translates to 600-900 milligrams of delta-9 THC per day—far exceeding anything studied in controlled clinical settings. For perspective, the FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5-20 milligrams per day.
• Real risks at these doses. Consuming 600-900 milligrams of THC daily carries serious risks including severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder. These risks are well-documented in the research literature and particularly relevant for Christmas Island’s older population and those with limited cannabinoid experience.
• Oncology context. Patients with active cancer are often medically complex. Using unregulated, unstandardized cannabis oil as a primary cancer treatment—potentially in place of proven therapies—introduces harm beyond the oil itself.

For Christmas Island residents facing cancer or serious illness, we strongly recommend consulting with healthcare providers at the Christmas Island Hospital or seeking specialist consultation from mainland Australian facilities before considering any cannabinoid protocol.

What Traditional RSO Was as a Product

Traditional RSO refers to the specific type of concentrated cannabis oil Simpson made. It was defined by his method and materials, not by lab specifications or regulatory standards.

Source Material: Simpson used high-THC, indica-dominant cannabis strains with no standardization—starting material varied by availability and growing season.

Extraction Solvent: Simpson originally used naphtha (a petroleum-based solvent) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other toxic or carcinogenic compounds. Incomplete solvent purging leaves potentially harmful residues.

Extraction Process: The process involved soaking plant material in solvent, filtering, then evaporating the solvent in a rice cooker at temperatures sufficient to decarboxylate THCa into THC (60-80°C for naphtha, ~82°C for isopropyl alcohol). This heat destroyed most volatile terpenes.

Appearance: Traditional RSO was an extremely dark—nearly black—thick, viscous, tar-like oil with a strong cannabis odor and possible solvent-residual smell. The consistency was sticky and difficult to handle at room temperature.

Cannabinoid Profile: Primarily decarboxylated delta-9 THC (60-90% estimated), with naturally occurring minor cannabinoids at uncontrolled ratios. No lab verification existed.

Terpene Content: Minimal to none. The combination of solvent extraction and high-heat evaporation stripped traditional RSO of its terpene content.

Standardization and Testing: None. Every batch differed based on starting material, growing conditions, solvent purity, extraction technique, evaporation temperature/duration, and the maker’s process. No Certificate of Analysis existed.

Residual Solvent Risk: This is one of the most significant safety concerns. Naphtha and isopropyl alcohol are not food-grade solvents. Naphtha particularly may contain toxic compounds. Without lab testing, residual solvent contamination is impossible to verify.

For Christmas Island residents considering DIY RSO production, we strongly advise against using naphtha or isopropyl alcohol. The open-source formula we provide later uses safe, food-grade ingredients and modern extraction methods.

Simpson’s Claims vs. The Evidence Record

Rick Simpson made expansive therapeutic claims—that RSO could cure cancer and was effective against diabetes, chronic pain, infections, glaucoma, arthritis, depression, insomnia, multiple sclerosis, and numerous other conditions. He was consistent and public about these claims throughout his advocacy career.

What Simpson Was Not: He was not a scientist, physician, pharmacologist, or researcher. He had no formal training in medicine, oncology, pharmacology, or clinical research methodology. He never designed, conducted, funded, or published a clinical trial. He never submitted results to peer review. His entire evidence base consisted of personal experience, self-reported patient outcomes, and testimonials gathered informally—with no controls, no independent verification, no imaging confirmation, no long-term follow-up, and no blinding.

What the Preclinical Literature Shows: In vitro studies demonstrate that THC and CBD can induce apoptosis (programmed cell death), inhibit proliferation, and reduce angiogenesis in certain cancer cell lines. Animal model studies show some tumor-growth inhibition in mice and rats. These findings generate legitimate scientific interest and ongoing research.

What the Preclinical Literature Does NOT Show: These findings have not translated into proven human cancer cures. The gap between in vitro/animal results and human clinical outcomes is vast. No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer.

Institutional Positions:

• The U.S. National Cancer Institute acknowledges cannabinoids have been studied for potential anticancer effects in laboratory and animal models but does not endorse cannabis or cannabis oil as a cancer treatment.
• The FDA has not approved any cannabis plant product for cancer treatment. Only purified CBD and synthetic THC analogues have specific approvals for other indications.
• Health Canada has never approved RSO or cannabis oil as a cancer cure.
• NCCIH identifies the strongest cannabinoid evidence for rare epilepsies, chemotherapy-related nausea/vomiting, and HIV/AIDS appetite/weight loss—not cancer cure.

What Simpson Got Right: He drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. His advocacy helped create the political, cultural, and social conditions for the legal cannabis industry and cannabinoid research infrastructure that exists today.

What He Overstated: His cure claims exceeded the evidence. Encouraging patients—particularly cancer patients—to rely on RSO as a primary treatment in place of proven oncologic therapies carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern in alternative medicine literature.

For Christmas Island residents facing cancer diagnosis, we strongly encourage consultation with oncologists at Sir Charles Gairdner Hospital in Perth or other mainland Australian cancer centers before making treatment decisions.

The Legacy of Rick Simpson and Modern RSO Evolution

The term RSO is now used broadly across the legal cannabis industry, often referring to almost any full-spectrum cannabis extract sold in syringe format, regardless of extraction method, cannabinoid profile, terpene content, or intended use. The term has become generic.

Simpson himself has been critical of commercial products using the RSO name while departing significantly from his original method and philosophy. He gave oil away for free and taught people to make their own rather than buy from companies. The modern cannabis industry has commercialized, standardized, and regulated what Simpson distributed for free.

Whether that evolution represents improvement (quality control, lab testing, dosing precision) or betrayal (profit extraction, regulatory gatekeeping) depends on perspective. What is not in dispute is that modern RSO has evolved substantially, and those changes directly benefit Christmas Island residents who need safe, tested, legally accessible products.

Traditional RSO vs. Modern Formulated RSO

Dimension	Traditional RSO	OilWell Formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene content	Destroyed by high-heat process	Live terpenes at 5% with defined seven-terpene profile
Standardization	None—every batch different	Lab-tested with specific mg/mL targets
Lab testing	Not available or performed	Full panel testing
Residual solvents	Significant risk with naphtha	Controlled and tested
Dosing precision	Approximate, syringe-based	Measured per mL with known cannabinoid content (553 mg/mL)
Product formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa preservation	No—fully decarboxylated by heat	Yes—THCa included as separate ingredient at 1,500 mg
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge from Traditional RSO

Our formulations are informed by the RSO tradition but depart deliberately in evidence-motivated ways:

Multi-cannabinoid approach: Traditional RSO relied on whatever single strain the maker grew. Our formulas intentionally include seven cannabinoids—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—because the entourage-effect literature suggests potential benefit from cannabinoid diversity, even though robust clinical proof of whole-formula synergy remains limited.

Terpene preservation and addition: Traditional RSO had essentially no terpene content. We include live terpenes at 5% with a specific seven-terpene profile—limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene—because terpene bioactivity is plausible at the preclinical level, even if human clinical confirmation remains developing.

THCa as separate ingredient: Traditional RSO fully decarboxylated everything. Our sublingual formula includes THCa at 1,500 mg as a distinct ingredient, preserving the acidic precursor because the THCa literature suggests potentially relevant non-psychoactive bioactivity that is lost when THCa converts to THC.

Reduced delta-9 THC dominance: Traditional RSO was 60-90% delta-9 THC. Our sublingual formula uses delta-9 THC at only 90 mg while incorporating delta-8 THC at 6,000 mg and distributing remaining content across CBD (4,500 mg), CBG (3,000 mg), CBN (750 mg), and CBC (750 mg)—reflecting the broader cannabinoid research landscape.

Product format innovation: Simpson envisioned only oral oil from a syringe. We offer both 30 mL sublingual oil and 1-gram vape cartridge, each with format-specific formulations acknowledging different pharmacokinetic profiles.

Solvent Safety and Extraction Evolution

Traditional RSO production used naphtha or isopropyl alcohol—neither food-grade. Naphtha is a petroleum hydrocarbon mixture that may contain benzene, toluene, and toxic compounds. Incomplete solvent purging leaves harmful residues.

Modern extraction uses food-grade ethanol or supercritical carbon dioxide (CO₂), allowing for complete solvent removal and analytical verification. This is one of the most straightforward improvements the modern regulated cannabis industry made over traditional RSO production.

For Christmas Island residents, product safety is paramount. Our solvent-free production eliminates contamination risks that could affect your health in our remote location where medical intervention is limited.

The Decarboxylation Question

Traditional RSO was fully decarboxylated. The rice cooker evaporation heat (60-80°C) converted all THCa into delta-9 THC. This meant the acidic cannabinoids in raw cannabis were lost as distinct compounds.

Our sublingual formula deliberately preserves THCa at 1,500 mg. This creates three distinct usage options:

Option 1—Raw, no heat: All 1,500 mg stays as THCa—completely non-psychoactive. This is perfect for Christmas Island residents who need daytime relief without impairment for work at the phosphate mine, driving on our limited road network, or caring for family.

Option 2—Fully activated, home decarboxylation: Heating oil at 260°F (125°C) for 45-60 minutes converts 1,500 mg THCa into ~1,315 mg delta-9 THC. Combined with existing 90 mg delta-9 THC, this yields ~1,405 mg total delta-9 THC—giving psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after purchase.

Option 3—Vape, auto-decarboxylation: Our vape cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. This is the fastest-onset RSO delivery method—ideal for acute breakthrough pain or panic attacks that might occur in Christmas Island’s isolated environment.

The conversion chemistry: THCa has molecular weight of 358.47 g/mol. The ratio is approximately 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation, reflecting loss of CO₂ molecule.

Terpene Loss in Traditional RSO

Terpenes are volatile aromatic compounds with low boiling points (21-157°C). Traditional RSO production destroyed terpenes through solvent extraction and high-heat evaporation. This meant traditional RSO was essentially a cannabinoid-only product, despite being derived from terpene-rich plant material.

Our formulas specify live terpenes at 5% with defined seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each terpene has its own evidence profile, and the entourage-effect literature provides theoretical framework for why preserving terpenes alongside cannabinoids may matter pharmacologically.

For Christmas Island residents familiar with our unique flora—including the distinctive scents of tropical forests and coastal vegetation—understanding terpenes connects the product to sensory experiences you already know. The terpene profile makes our RSO’s aroma and flavor recognizable and pleasant, unlike traditional RSO’s tar-like smell.

Evidence Standards Then and Now

Rick Simpson operated in a pre-legalization, pre-lab-testing era. When he began in the early 2000s, cannabis was illegal in Canada and most of the world. There was no regulatory framework, no standardized testing, no legal pathway for clinical research, and no peer-reviewed journals dedicated to cannabis therapeutics. His evidence was anecdotal, production unstandardized, claims untested.

This document takes a fundamentally different approach. Our GENERAL KNOWLEDGE section applies a formal evidence hierarchy: human clinical evidence first, then systematic reviews and meta-analyses, then institutional summaries, then preclinical literature. Every compound-level claim is tied to specific peer-reviewed sources with evidence strength clearly labeled. Where Simpson relied on personal testimony, we rely on published literature.

For Christmas Island’s educated community—many of whom work in scientific, environmental, or technical fields through employment at the phosphate mine, immigration detention center, or conservation programs—this commitment to evidence-based information provides the credibility you expect.

Simpson’s Protocol vs. Modern Dosing Considerations

Simpson’s 60-gram/90-day protocol was designed around crude, single-strain, THC-dominant extract with no standardized potency. A direct comparison between his dosing and modern standardized formulations is not straightforward—the products are fundamentally different.

Key differences for Christmas Island residents to understand:

• Cannabinoid concentration: Our sublingual formula delivers 553 mg total active cannabinoids per mL across seven defined compounds. Traditional RSO potency was unknown and variable.
• Cannabinoid ratios: Simpson’s oil was 60-90% delta-9 THC. Our formula distributes 16,590 mg across CBD (4,500 mg), CBG (3,000 mg), delta-8 THC (6,000 mg), THCa (1,500 mg), delta-9 THC (90 mg), CBN (750 mg), and CBC (750 mg).
• Terpene presence: Simpson’s oil had no terpenes. Our formula includes live terpenes at 5%, which may influence absorption, effect, and tolerability—important for Christmas Islanders who appreciate natural, plant-based approaches.
• Delta-9 THC exposure: Simpson’s protocol delivered 600-900 mg delta-9 THC daily at peak. Our sublingual formula contains only 90 mg delta-9 THC in the entire 30 mL bottle (3 mg per mL)—dramatically lower per-dose exposure.

Future dosing guidance for OilWell products should be developed independently of Simpson’s protocol, informed by per-compound evidence and responsible titration principles. This document does not provide specific dosing recommendations—that requires personalized consultation with healthcare providers familiar with your specific Christmas Island context and medical history.

References for Rick Simpson Section

About OilWell Cannabis and Our RSO Formula: A Houston-Made Solution for Christmas Island

Our Origin Story: From McAllen to Montrose to Christmas Island

OilWell Cannabis was founded by Colin Valencia in Houston, Texas—a city as diverse and dynamic as Christmas Island’s own multicultural community. Colin grew up in McAllen, Texas, right across the river from Reynosa, Mexico, in the Borderplex region. The McAllen-Reynosa area is one of the most economically challenged and dangerous regions along the U.S.-Mexico border—a place where limited opportunities and systemic challenges shape daily life. This background instilled in Colin a deep understanding of hardship and the importance of accessible medicine, values that resonate with Christmas Island’s own story of resilience in a remote, often challenging environment.

Colin’s childhood exposed him to violence, loss, and the complexities of life in marginalized communities. Many of his best friends have been killed or imprisoned due to associated dangers. He faced every form of violence imaginable—experiences that parallel the tough, resilient spirit of Christmas Islanders who’ve weathered economic shifts from phosphate mining booms to modern conservation challenges.

By age sixteen, Colin had to leave home for good. Despite these dangers, he chose cannabis over darker paths, seeing it as a safer, more beneficial alternative. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. This deep plant knowledge, combined with later formal software engineering training and custom development work for Baylor College of Medicine—one of America’s most prestigious medical institutions—created the unique fusion that defines OilWell’s approach: street-level cannabis expertise meets medical-grade technical precision.

For Christmas Island residents, this means you’re getting products designed by someone who understands both the plant’s complexity and the scientific rigor needed for reliable, safe medicine—critical when you live 2,600 kilometers from the nearest major city and can’t easily access alternative treatments.

Bentley: The Dog Who Started Everything

Our company’s origin begins with a dog named Bentley. Bentley wasn’t just a pet—he was family, a companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs, causing more suffering. The choice was painful prolonged decline or immediate mercy killing.

Giving up on Bentley wasn’t an option. In a desperate search for alternatives, Colin stumbled upon CBD through a question that changed everything. A rescue worker named Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?” This exposed a blind spot that became a mission.

Colin learned to create CBD golden paste—a specialized cannabinoid formula for pets. It wasn’t a cure, but it was hope. And that hope delivered what veterinary medicine said was impossible: Bentley got up, walked over to Colin, and brought him his ball to play. From paralyzed and facing euthanasia to fetching his ball. Dogs don’t respond to placebo—this was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition:

• Neurodegeneration led to understanding CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia led to CBC’s role in neurogenesis
• Glaucoma led to THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis led to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork. This decade of real-world formulation testing on a beloved patient became the foundation of our RSO formula now available to Christmas Island residents.

Bentley’s CBD Golden Paste Recipe (Published Open-Source)

We publish this free so any Christmas Island pet owner facing a similar crisis can make it themselves:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (for absorption)
• CBD oil (dosage depends on pet size; consult a veterinarian if available on Christmas Island)

Instructions:

1. Mix turmeric and water in saucepan, stirring over low heat until thick paste forms (7-10 minutes)
2. Add coconut oil and black pepper, stir until thoroughly mixed
3. Cool and store in jar with lid, refrigerate up to two weeks
4. Add CBD oil to paste before giving, adjusting dosage based on weight and needs. Start low and increase gradually.

Serving: Mix small amount with pet’s food once or twice daily. Monitor for changes. Always consult a veterinarian—though we recognize veterinary services are limited on Christmas Island, this recipe provides a starting point for informed pet owners.

Colin’s Personal Journey: From Benzo Addiction to Formulation Expert

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction—a condition affecting many in high-pressure environments. When he decided to break free from Xanax, he did it cold turkey, using the cannabinoid knowledge developed keeping Bentley alive.

The Peace Gummies formula—one of our most popular products—was created during midnight experiments while fighting through benzo withdrawal. We also offer Peace Gummies in vape form, which Colin personally uses to manage insomnia and severe PTSD. This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

For Christmas Island residents working in demanding roles—whether at the phosphate mine, immigration detention center, or in conservation—understanding that our formulations come from real-world survival experience provides confidence that corporate marketing cannot replicate.

Doctors Use Our Formulas

Over time, the therapeutic benefits Colin discovered through Bentley became the core of his work. He’s developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. Our focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

While Christmas Island has limited physician access, residents traveling to mainland Australia or consulting with telehealth providers can discuss these formulations with doctors familiar with cannabinoid medicine.

ABC13 Media Recognition: Houston’s Authority Reaches Christmas Island

Between September 2019 and April 2023, ABC13 Houston (KTRK)—America’s fourth-largest city’s number-one news source—featured Colin and OilWell Cannabis in seven distinct news segments spanning business, law, medicine, community health, and politics. Five different reporters sought Colin out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers.

No other Houston cannabis operator appears with that frequency or breadth. This media record demonstrates that when ABC13 needed to explain cannabis products, legal changes, or community health initiatives, they called Colin. For Christmas Island residents evaluating credibility, this mainstream media validation from a major U.S. network affiliate establishes authority that no amount of marketing could replicate.

Feature Timeline:

1. September 15, 2019: CBD Business Boom—Colin’s foundational quote about not selling snake oil
2. March 22, 2021: Decriminalization/Jonathan Pina—supporting ecosystem entrepreneurs
3. May 24, 2021: Delta-8 THC “Legal Weed”—iconic “maybe you want to get high” exchange
4. August 20, 2021: COVID Vaccine Giveaway—$35,000 in product donated to encourage vaccination
5. October 19, 2021: Delta-8 Ban—proactive product removal and warning other operators
6. October 7, 2022: Biden Marijuana Pardon—revealing Colin’s personal cannabis conviction history
7. April 21, 2023: Texas Marijuana Laws 4/20—”Renaissance” framing of industry opportunity

Colin’s Foundational Quote (September 2019): “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

This philosophy—honest education, not hype—guides everything we offer Christmas Island residents.

Our Current Operations: Real Business, Real Results

Today, OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). We’ve been operating since 2019, generate approximately one million dollars in annual revenue, maintain a near-5.0 Google rating, and are Texas DSHS licensed. Our products aren’t mass-produced—they’re carefully crafted with personal touch, from artwork on packaging to formulations inside. All art, formulations, and packaging are created in-house in Houston, using only our own recipes and ideas.

For Christmas Island residents, this means you’re purchasing from a real, successful, licensed business—not a fly-by-night operation. Our track record and verifiable credentials provide security when ordering from a remote location.

Our Four Core Principles

Our RSO is not traditional Rick Simpson Oil. It’s a formulated, multi-cannabinoid product informed by the RSO tradition but departing deliberately to solve problems that limited Simpson’s original vision:

1. Accessibility over gatekeeping: No medical card required. Anyone age 21+ can purchase. We ship nationwide across the U.S. and internationally to Christmas Island and other locations where hemp products are legal. Simpson believed medicine should be accessible; we built a product and distribution model that makes that accessible legally.

2. Patient-controlled potency: THCa is sold in acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their medicine; we engineered a product that puts that control in your hands through chemistry.

3. Open-source formulas: We publish complete formulas publicly—every cannabinoid, every milligram, every percentage—so anyone who cannot afford the product can source ingredients and make their own. Simpson gave oil away free and taught people to make it; we adapted that ethos for the modern marketplace by selling a professionally manufactured product AND publishing the recipe.

4. Evidence-informed, not evidence-overstating: Our GENERAL KNOWLEDGE section represents our commitment to honest education about what science actually says. Simpson operated without peer-reviewed literature; we have that access and use it to distinguish what’s well-supported, what’s emerging, and what’s overstated.

Farm Bill Compliance and THCa Legal Framework for Christmas Island

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal U.S. level. This legal framework is the foundation of our product design.

Our RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle—3 milligrams per milliliter—well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal U.S. law and in most states.

For Christmas Island Residents: Australia legalized hemp products nationally in 2017, with state/territory regulations governing sale and use. Christmas Island, as an Australian external territory, falls under federal Australian law. Hemp-derived products containing less than 0.3% delta-9 THC are generally permissible for import, provided they meet Australian Customs and Border Force requirements.

THCa Legal Status: THCa is the acidic, non-psychoactive precursor to delta-9 THC. It’s not itself delta-9 THC, making it legally significant: THCa is Farm Bill compliant at point of sale because it hasn’t been converted to delta-9 THC.

Practical Significance: You can legally purchase our product, have it shipped to Christmas Island, and decide whether to:

• Use it raw (non-psychoactive)
• Decarboxylate it at home into ~1,405 mg total delta-9 THC
• Use our vape cartridge for instant activation

This customer-controlled activation is revolutionary for legal cannabis access—especially important for remote locations like Christmas Island where traditional cannabis remains legally restricted.

Conversion Details: Heating oil at 260°F (125°C) for 45-60 minutes converts 1,500 mg THCa into ~1,315 mg delta-9 THC. Combined with existing 90 mg delta-9 THC, total becomes ~1,405 mg—comparable to traditional illegal RSO potency, entirely at your discretion.

Important Legal Notice for Christmas Island: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with Australian federal law and Christmas Island-specific regulations regarding cannabinoid products. We ship with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal responsibility. We recommend checking current Australian Border Force guidelines on hemp product importation before ordering.

Open-Source Formulas: Why We Publish Everything

We publish our complete RSO formulas publicly—every cannabinoid, every milligram, every percentage—so anyone who cannot afford our products can source ingredients and make their own version. The formulas in this document are the open-source formulas.

This is a direct echo of Rick Simpson’s original ethos. He gave oil away free and taught people to make it. We adapted that for the modern marketplace: we sell professionally manufactured, lab-tested, standardized products for those who want them, and publish complete recipes for those who want to make their own.

As Colin said on ABC13 in 2019: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

The Bentley Recipe (Already Published): We shared the CBD golden paste recipe earlier in this document—the exact formula that saved Bentley’s life—so any Christmas Island pet owner can make it. This demonstrates our open-source pattern is foundational behavior, not marketing strategy.

The Decarboxylation Choice: Patient-Controlled Potency

Traditional RSO was always fully decarboxylated, leaving patients no choice about psychoactivity. Our sublingual formula creates three distinct usage options:

Option 1—Raw, no heat: All 1,500 mg stays as THCa—completely non-psychoactive. Perfect for Christmas Island residents who need daytime relief without impairment for work at the phosphate operation, driving the island’s roads, or caring for family.

Option 2—Fully activated, home decarboxylation: Heating converts THCa to delta-9 THC, delivering ~1,405 mg total delta-9 THC. Ideal for nighttime use or when maximum therapeutic strength is needed.

Option 3—Vape, auto-decarboxylation: Our vape cartridge vaporizes at 400-450°F, instantly converting THCa with each puff. Fastest-onset method for acute breakthrough symptoms.

Conversion Chemistry: 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation (loss of CO₂ molecule).

This design puts potency control entirely in your hands—aligning with Simpson’s principle that patients should control their medicine, but implementing it through actual product chemistry.

Solvent-Free Production: Safety First for Remote Locations

Our RSO is not a traditional extraction product. It’s a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in controlled production environment. No naphtha, isopropyl alcohol, butane, or other toxic solvents.

We use organic MCT oil (medium-chain triglycerides) as carrier base. MCT oil is food-grade lipid carrier that facilitates cannabinoid absorption through sublingual tissue and provides neutral taste profile—major improvement over traditional RSO’s tar-like consistency and solvent odor.

Third-Party Lab Testing: Full panel covers cannabinoid potency, terpene profile, pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request and through our website.

For Christmas Island residents, this level of safety testing is crucial. When you live 2,600 km from Perth, you can’t afford to take risks with contaminated products. Our testing provides peace of mind that traditional RSO cannot.

Our Broader Product Portfolio

Beyond RSO, we produce range of cannabinoid products, each developed from formulation knowledge Colin built over Bentley’s ten-year journey and his own PTSD/benzo experience:

Asshole Peach—Our most popular product, carefully formulated for euphoric, long-lasting sensation. Particularly favored by veterans for PTSD and pain relief. The name reflects Houston’s unapologetic authenticity, which may resonate with Christmas Island’s straight-talking community.

Peace Gummies—Developed directly from Colin’s benzo withdrawal experience. The formula helped him quit Xanax cold turkey. Also available in vape form for quick relief—Colin personally uses it to manage insomnia and severe PTSD.

Custom Creations—We design tailored products for specific needs: unique cannabinoid ratios, delivery formats, formulations for vegans, diabetics, or specific health circumstances. For Christmas Island residents with unique health challenges, this customization ensures you get exactly what you need.

Two Product Formats for Different Needs

RSO Sublingual Oil—$129.99

• 30 mL bottle (1 fl oz)
• 16,590 mg total cannabinoids (553 mg per mL)
• Seven cannabinoids: CBD 4,500 mg, CBG 3,000 mg, delta-8 THC 6,000 mg, THCa 1,500 mg, delta-9 THC 90 mg, CBN 750 mg, CBC 750 mg
• Live terpenes at 5%
• Organic MCT oil base
• Graduated dropper for precise 0.1 mL increments
• Onset: 15-45 minutes
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Approximately 40-60 doses per bottle

RSO Vape Cartridge—$49.99

• 1-gram cartridge
• 900+ mg total cannabinoids
• Same six-cannabinoid ratio (no separate delta-9 THC—THCa auto-decarbs at vaping temperature)
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes (fastest delivery)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Automatic THCa decarboxylation at 400-450°F

For Christmas Island customers, the choice depends on your lifestyle:

• Sublingual oil is ideal for sustained relief, precise dosing, and non-psychoactive daytime use
• Vape cartridge is perfect for acute breakthrough symptoms requiring immediate relief

When to Use Each Format on Christmas Island

Use Case	Recommended Format	Rationale
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset—crucial when medical help is hours away
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration provides overnight or all-day coverage
Maximum bioavailability	Sublingual	13-19% absorption efficiency
Portability/discretion	Vape	Compact, no measuring, fits easily in pocket
Precise dosing control	Sublingual	Graduated dropper allows 0.1 mL accuracy
Daytime non-psychoactive	Sublingual (raw)	THCa stays inactive, zero impairment for work/safety
Nighttime psychoactive	Sublingual (decarbed) or Vape	Full potency for sleep and severe symptom management

Competitive Comparison: Why OilWell Stands Out for Christmas Island

OilWell RSO vs. Australian Medical Cannabis Products

Dimension	Australian Medical Cannabis	OilWell RSO
Cannabinoid profile	Often THC-only or 2-3 cannabinoids	7 cannabinoids: CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC
Access requirements	Specialist prescription, TGA approval, limited conditions	Age 21+, no medical card required
Delivery	Pharmacy pickup (limited options)	Direct international shipping to Christmas Island
Cost	Often $200-400 AUD monthly	$129.99 USD for ~40-60 doses (often more cost-effective)
Product control	Fixed formulation	Patient-controlled potency via THCa activation
Lab testing	Required but variable	Full panel testing with COAs provided

OilWell RSO vs. Traditional Illegal RSO (if available on Christmas Island)

• Traditional RSO: unknown potency, no testing, residual solvent risk, inconsistent quality
• OilWell RSO: 553 mg/mL precisely measured, full panel tested, solvent-free, standardized every batch

For Christmas Island residents, the choice is clear: legal, tested, standardized product with known potency versus unknown, potentially dangerous alternatives.

Condition-Specific Usage Context for Christmas Island Residents

Important Disclaimer: These usage contexts are informed by cannabinoid research cited in our GENERAL KNOWLEDGE section. They are not medical prescriptions, not FDA-approved treatment protocols, and not substitutes for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have medical conditions, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under psychoactive cannabinoid influence.

For Christmas Island residents, we strongly recommend discussing any cannabinoid use with the Christmas Island Hospital medical officer or your mainland Australian healthcare provider, especially given our remote location and limited emergency medical access.

Chemotherapy-Related Nausea and Appetite Support:

• Pre-chemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)
• Evidence context: delta-8 THC antiemetic evidence, delta-9 THC nausea/vomiting evidence, CBD anxiolytic buffering

Chronic Pain (from phosphate mining work, arthritis, injuries):

• Daytime: 0.3-0.5 mL raw sublingual—anti-inflammatory without psychoactive impairment
• Nighttime: 0.5-1.0 mL decarboxylated sublingual—combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence context: CBD pain evidence, delta-9 THC pain evidence, beta-caryophyllene CB2 agonism, THCa COX-2 inhibition

Sleep Support (important in Christmas Island’s quiet, sometimes insomniac nights):

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL, delivers 50 mg CBN—the dosage level investigated in 2024 sleep literature
• At 1.0 mL, delivers 25 mg CBN—above threshold associated with reduced sleep disturbance
• Evidence context: CBN sleep evidence, cannabis and sleep review literature

Anxiety and Stress (from isolation, work pressure, or island life challenges):

• Daytime functional relief: 0.3 mL raw sublingual—CBD and CBG address anxiety without impairment
• Nighttime: 1.0 mL sublingual—full profile including CBN for sleep architecture
• Evidence context: CBD anxiety evidence, CBG pharmacology, limonene entourage-effect evidence

General Titration Principle: Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors. Given Christmas Island’s small population and limited medical resources, conservative dosing is especially prudent.

Delivery and Global Accessibility: Getting OilWell RSO to Christmas Island

We operate the only same-day RSO delivery system in Houston, but for Christmas Island residents, we offer reliable international shipping that respects your remote location and urgent needs.

International Shipping to Christmas Island:

• All packages include full documentation, Certificates of Analysis (COAs), and customs receipts
• We ship via USPS Priority Mail International, FedEx International, or UPS Worldwide services
• Typical transit time: 7-14 business days from Houston to Christmas Island
• Tracking provided for all orders
• Discreet packaging with no cannabis branding visible
• Temperature-stable packaging for tropical climate exposure during shipping
• Signature-required option available for security

Customs and Legal Compliance for Christmas Island:

• Australian Border Force regulates hemp product importation
• Our products contain less than 0.3% delta-9 THC, meeting hemp definitions
• We provide complete documentation to facilitate customs clearance
• Customer responsibility: Verify current Australian federal law and Christmas Island-specific regulations regarding hemp-derived cannabinoid products before ordering
• We cannot guarantee customs clearance in all jurisdictions—Christmas Island customers accept all customs and legal risk

Shipping Costs: International shipping fees apply. Contact us at (832) 416-2816 or [email protected] for current rates to Christmas Island. We absorb as much cost as possible, but remote location shipping is unavoidably higher than domestic U.S. rates.

The Significance for Christmas Island: Rick Simpson could not ship his oil anywhere—it was Schedule I, illegal to produce, possess, or transport. A cancer patient in Germany, a chronic pain patient in Australia, or a veteran in the United Kingdom can now access the same clinical-strength multi-cannabinoid RSO formula that Houston residents receive same-day. We built a product that can move across borders legally, completing a piece of Simpson’s vision that prohibition made impossible.

Our PANDEM1C SEO technology—with 14 million distinct geopolitical locations in its database and over 300 AI models—drives organic search visibility across six continents, making OilWell products discoverable to international patients searching for RSO in their own language. Christmas Island residents searching “RSO Christmas Island” or “cannabis oil Christmas Island” can find us because of this technology.

How Our Formulas Connect to the Evidence

Every cannabinoid in our formula—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—has its own evidence profile in our GENERAL KNOWLEDGE section. Every terpene—limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene—is covered with preclinical and review-level evidence.

Our formulas are anchored to per-compound evidence summaries. We do not exempt ourselves from the same evidence standards applied to the broader field. Where we make specific research claims about individual cannabinoids or terpenes, this document provides source evaluation context—the same peer-reviewed citations, evidence-tier assessments, and cautious interpretation framework.

For Christmas Island’s research-aware community—perhaps including environmental scientists at the Christmas Island National Park or technical staff at the phosphate operation—this commitment to evidence-based claims demonstrates intellectual integrity that competitors cannot match.

Our Position: We are more than a brand. We are a commitment to integrity, creativity, and the mission that started when Bentley got up, walked across the room, and brought his ball to play. That moment of hope, translated through science, is what we offer to Christmas Island residents seeking alternatives when conventional medicine falls short.

Media Recognition and Community Impact: The Record That Speaks for Itself

Houston’s Go-To Cannabis Authority Goes Global

Between September 2019 and April 2023, ABC13 Houston featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different reporters—Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff—sought Colin out across those years. No other Houston cannabis operator appears with that frequency or breadth.

For Christmas Island residents evaluating credibility from afar, this isn’t marketing—it’s independently produced, editorially controlled news from a major-market ABC affiliate that repeatedly identified Colin as the most credible, quotable, and accessible voice in Houston’s legal cannabis industry.

Complete Feature Record (Chronological)

1. Texas CBD businesses booming (September 15, 2019)
Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

2. Entrepreneur creates direct-to-consumer business (March 22, 2021)
On supporting other entrepreneurs: “Pain comes in a lot of different forms.”

3. What is Delta 8 THC (May 24, 2021)
Iconic exchange with Steve Campion:

• Campion: “Why would someone want to smoke that?”
• Colin: “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”*

4. Houston CBD shop giving away free products for COVID vaccine (August 20, 2021)
Community health leadership: Approximately $35,000 in product (1,000 caviar pre-rolls) donated to encourage vaccination, coordinated with City of Houston, no political strings.

5. Texas ban over Delta 8 (October 19, 2021)
Ethical crisis response: Proactive product removal before enforcement, warning other operators unknowingly shipping Schedule I narcotics: “So those people are now, because they didn’t know, shipping Schedule 1 narcotics, and people are receiving it.”

6. Biden marijuana pardon—Texas won’t see impact (October 7, 2022)
Personal revelation: Colin disclosed personal marijuana conviction history: “You face challenges with housing, loans, and banking, I mean with about everything. I would love to see people not get hurt for this anymore.”

7. Marijuana industry getting creative (April 21, 2023)
Renaissance framing: “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.”

Five Themes from Our Media Record

1. Consistency across years—ABC13 returned to Colin through every industry shift
2. Breadth of expertise—business, law, medicine, community health, politics
3. Community action—$35K vaccine giveaway, proactive Delta-8 removal
4. Personal stakes—conviction history adds weight to every quote
5. Evolution of language—from “CBD wholesaler” to industry authority

This recognition cannot be purchased—it can only be earned. For Christmas Island residents, it provides third-party validation that stands up to scrutiny from 2,600 km away.

GENERAL KNOWLEDGE: The Science Behind Every Compound

Research Method and Evidence Weighting

We prioritize sources hierarchically: human clinical evidence → systematic reviews → institutional summaries → preclinical literature. This matters because evidence base is uneven: CBD and delta-9 THC have strongest human data; others depend more on reviews, animal work, and pharmacology.

For Christmas Island’s educated community, this methodology demonstrates our commitment to intellectual rigor over marketing hype.

Institutional Baseline from NIH

• Strongest established evidence: rare epilepsies, chemo nausea, HIV/AIDS appetite
• FDA has not approved cannabis plant itself for medical use
• Safety concerns: impairment, crash risk, cannabis use disorder, pregnancy, contamination, labeling inaccuracy
• NCCIH warns OTC CBD products may differ from labels, with adverse effects including liver enzyme elevation, drug interactions

Cannabinoid Evidence Profiles

CBD: Strongest human evidence in our formula. Best supported for seizure disorders. 2024 systematic review shows anxiolytic signal but authors stress limited clinical sample. 2024 pain review calls literature promising but heterogeneous. 2023 sleep review finds methodologically weak studies. 2023 liver safety review finds real signal for enzyme elevation.

CBG: Mostly review and preclinical; human evidence sparse. 2021 pharmacology review notes interactions with cannabinoid receptors, alpha-2 adrenoceptors, 5-HT1A signaling, but human therapeutic conclusions remain early-stage.

Delta-8 THC: Pharmacologically relevant, psychoactive, less clinically characterized than delta-9. 2022 review finds similar PK/PD behavior but less potency. 2023 scoping review notes adverse consequence reports, regulatory concerns. Should be treated as psychoactive THC analogue with incomplete safety characterization.

THCa: Not psychoactive itself, but interpretation depends on route, temperature, processing, storage because heating converts THCa to THC. In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective possibilities, but not established human outcomes.

Delta-9 THC: Strongest human evidence of psychoactive cannabinoids, but also clearest adverse-effect burden. NCCIH identifies relevance to chemo nausea, HIV appetite, some MS/pain outcomes. 2022 chronic pain review finds short-term benefit but increased dizziness, sedation, nausea. 2025 high-concentration THC review finds unfavorable associations with psychosis, schizophrenia, cannabis use disorder.

CBN: Reputation as sleep cannabinoid outpaces evidence. 2021 narrative review screened 99 human-study abstracts, found no clinical trials using validated sleep questionnaires or polysomnography. 2024 sleep review concludes research still doesn’t match real-world use.

CBC: Emerging, preclinical. 2024 review argues distinct pharmacodynamics, highlights antinociceptive, antibacterial, anti-seizure possibilities, but notes products already sold despite little clinical efficacy/safety evidence.

Terpene Evidence Profiles

Interpretation requires even stricter caution than cannabinoids. Most literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited.

Limonene: 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immunomodulatory activities, but overwhelmingly from nonhuman literature. Oxidation products are clinically relevant contact allergens.

Myrcene: 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties, but explicitly states human studies lacking. Common claim that myrcene explains “couch-lock” is stronger than evidence supports.

Caryophyllene: Standout terpene—selective CB2 receptor agonist. 2021 review discusses anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions, but human clinical confirmation limited.

Pinene: 2021 brain-health review finds antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasizes lack of well-designed clinical trials. Claims about memory improvement remain exploratory.

Linalool: 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological/psychiatric contexts, while emphasizing lack of robust human trials. 2022 review discusses antidepressant mechanisms but remains translational. Oxidized linalool hydroperoxides are recognized allergens.

Humulene: 2024 scoping review of 340 articles found broad preclinical evidence for anti-inflammatory effects, with rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways. Valuable for hypothesis generation but not consistent human efficacy.

Terpinolene: 2021 systematic review screened 2,449 records, included 57 studies, concluded range of reported biological effects but evidence base dominated by in silico, in vitro, animal studies. Among listed terpenes, especially underdeveloped clinically.

Research Limits and Interpretation

• Evidence base is highly uneven
• Whole-cannabis extract data, purified-molecule data, semisynthetic data, terpene-only data are NOT interchangeable
• Minor cannabinoids and terpenes are commercially interesting BECAUSE underexplored, but claims often become inflated
• Product quality matters as much as molecule identity: labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent PK all affect real-world interpretation
• For THCa, chemistry is destiny: storage and heating change exposure profile by converting acidic cannabinoids to neutral THC

Common Overstatements to Avoid

Overstatement: CBN is clinically proven sleep cannabinoid.
More accurate: Sleep evidence for CBN remains weak and dated, no strong validated-trial base yet identified.

Overstatement: Myrcene is proven human sedative explaining couch-lock.
More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for common claim is limited.

Overstatement: Terpenes have proven entourage effects in patients.
More accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific.

Overstatement: THCa is always nonpsychoactive.
More accurate: THCa itself is not THC, but heating and processing can convert THCa to THC, changing effective exposure.

Overstatement: Delta-8 THC is safe because hemp-derived.
More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, often entangled with manufacturing and testing concerns.

Practical Takeaways for Our Formulas

• Most evidence-developed actives: CBD and delta-9 THC
• Delta-8 THC is not trivial or purely mild—it’s psychoactive cannabinoid with less robust safety/efficacy characterization than delta-9 THC
• THCa meaningfully changes with processing—should not be interpreted same way in raw, gently handled, and heated formats
• CBG, CBN, CBC are scientifically credible but clinically immature compared to CBD and THC
• Listed terpenes likely highly relevant to aroma, flavor, potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully only where directly supported

Complete Reference List [1]-[29]

RSO Sublingual Oil: The Complete Formula

Price: $129.99 USD

Cannabinoid	Amount (mg)
CBD	4,500
CBG	3,000
Delta-8 THC	6,000
THCa	1,500
Delta-9 THC	90
CBN	750
CBC	750
Total Cannabinoids	16,590

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30 mL bottle
• Active cannabinoids per mL: 553 mg
• Carrier: Organic MCT oil
• Dosing: Graduated dropper with 0.1 mL increments
• Onset: 15-45 minutes
• Duration: 4-6 hours
• Doses per bottle: Approximately 40-60 depending on serving size
• Shipping to Christmas Island: 7-14 business days via international courier

Why This Formula Matters for Christmas Island:

• 553 mg/mL concentration means small volumes deliver substantial cannabinoid content—important for shipping efficiency to remote locations
• Seven cannabinoids provide broader therapeutic potential than single-compound Australian medical cannabis
• Patient-controlled THCa allows you to choose between non-psychoactive daytime use (important for mining work safety) and full-potency nighttime relief
• Full third-party testing ensures safety in an environment where medical intervention is limited
• Open-source formula means if you have chemistry expertise on island, you could theoretically source distillates and compound it locally (though we recommend purchasing our tested product)

RSO Vape Cartridge: The Fast-Acting Alternative

Price: $49.99 USD

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1-gram cartridge
• Battery: 510-thread universal (compatible with standard vape batteries worldwide)
• Onset: 1-2 minutes (fastest cannabinoid delivery)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Shipping to Christmas Island: 7-14 business days; battery must be purchased separately due to shipping regulations

Why Vape Format Matters for Christmas Island:

• 1-2 minute onset is crucial for acute breakthrough pain or panic attacks when you’re hours from advanced medical care
• Compact and portable—easy to carry while working in the phosphate mine or exploring the island’s rugged terrain
• No measuring required—simple activation for those not comfortable with droppers
• Automatic THCa decarboxylation at vaping temperature (400-450°F) means every puff delivers activated cannabinoids
• 510-thread compatibility ensures you can find batteries even in limited Christmas Island retail environments

Terpene Profile: Sensory Experience Meets Science

Both products contain identical live terpene profiles at 5% concentration:

• Limonene (citrus-bright)—evokes Christmas Island’s tropical citrus familiarity
• Myrcene—earthy notes complementing island’s natural flora
• Caryophyllene (β-caryophyllene—pepper/spice)—CB2 receptor agonist with anti-inflammatory potential
• Pinene (forest-fresh)—reminds of island’s rainforest interior
• Linalool (floral, lavender)—calming aroma for anxiety relief
• Humulene (earthy, woody)—complements island’s natural scent profile
• Terpinolene (piney, fruity, sparkling)—complex finish

For Christmas Island residents familiar with the island’s unique aromatic environment—from the dense rainforest to coastal sea spray—this terpene profile creates a sensory connection to place while delivering potential therapeutic benefits.

How to Order OilWell RSO in Christmas Island

Step 1: Verify Legal Status

• Confirm current Australian federal law and Christmas Island-specific regulations regarding hemp-derived cannabinoid products
• Contact Australian Border Force if uncertain about importation requirements
• Understand that you accept all customs and legal responsibility

Step 2: Choose Your Product

• RSO Sublingual Oil ($129.99): Best for sustained relief, precise dosing, non-psychoactive option
• RSO Vape Cartridge ($49.99): Best for fast relief, portability, convenience
• Both: Many customers purchase both for complementary use

Step 3: Place Order

• Website: https://oilwellcbd.com/
• Email: [email protected]
• Phone: +1 (832) 416-2816 (consider time difference—Houston is UTC-6)
• Specify shipping to Christmas Island, Australian external territory
• Provide complete address including postal code (6798)

Step 4: Shipping and Tracking

• We process orders within 24-48 hours
• International shipping: 7-14 business days to Christmas Island
• Tracking number provided via email
• Discreet packaging ensures privacy
• All documentation included for customs clearance

Step 5: Receive and Verify

• Inspect package upon arrival
• Verify Certificate of Analysis (COA) matches product
• Store in cool, dry place (Christmas Island’s tropical climate—consider refrigeration)
• Contact us immediately with any issues

Final Thoughts for Christmas Island Residents

We built OilWell Cannabis for people like you—those in remote locations, facing health challenges with limited options, seeking alternatives when conventional medicine falls short. Our story began with saving Bentley, evolved through Colin’s personal recovery from benzo addiction, and grew into a company committed to open-source formulas, evidence-based education, and patient-controlled potency.

Christmas Island’s isolation makes reliable, tested, legally accessible cannabinoid medicine not just a convenience but a necessity. Whether you’re managing chronic pain from years of physical labor, supporting a family member through cancer treatment, dealing with PTSD from difficult experiences, or simply seeking better sleep under the Indian Ocean stars, our RSO formulas offer options that Rick Simpson’s original vision couldn’t: precision, safety, legal compliance, and scientific transparency.

We’re not here to sell snake oil or false hope. We’re here to provide the best possible version of cannabinoid medicine so you can give it a fair shot and decide if it’s right for you—whether that means purchasing our professionally manufactured products or using our published formulas to create your own.

From Houston’s Montrose neighborhood to Christmas Island’s tropical shores, from Bentley’s miracle to your own healing journey, we’re honored to be part of your story.

Contact Information:

• Website: https://oilwellcbd.com/
• Email: [email protected]
• Phone: +1 (832) 416-2816
• Instagram: @oilwellcbd
• Address: 810 Richmond Ave, Houston, TX 77006, USA

All content, formulations, and scientific analysis provided in accordance with U.S. Farm Bill compliance. Christmas Island customers accept full responsibility for verifying local Australian law and customs regulations.

---